
(
  (S
    (NP (JJ Rheumatoid) (NN arthritis) (NN synovium))
    (VP (VBZ contains)
      (NP (NN plasmacytoid) (JJ dendritic) (NNS cells)))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (NP
          (NP
            (ADJP (RB previously) (VBN described))
            (NN enrichment))
          (PP (IN of)
            (NP
              (NP (JJ antigen-presenting) (JJ HLA-DR+) (JJ nuclear) (NN RelB+) (JJ dendritic) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NNS DCs))
                (-RRB- -RRB-)))))
        (PP (IN in)
          (NP
            (NP
              (NP (JJ rheumatoid) (NN arthritis))
              (PRN (-LRB- -LRB-)
                (NP (NN RA))
                (-RRB- -RRB-)))
            (NN synovium)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ CD123+HLA-DR+) (NN plasmacytoid) (NNS DCs))
          (PRN (-LRB- -LRB-)
            (NP (NNS pDCs))
            (-RRB- -RRB-)))
        (CC and)
        (NP (PRP$ their) (NNS precursors)))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN identified)
            (PP (IN in)
              (NP
                (NP
                  (NP (JJ human) (JJ peripheral) (NN blood))
                  (PRN (-LRB- -LRB-)
                    (NP (NN PB))
                    (-RRB- -RRB-)))
                (, ,)
                (NP (JJ lymphoid) (NN tissue))
                (, ,)
                (CC and)
                (NP (DT some) (JJ inflamed) (NNS tissues))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD hypothesized)
        (NP
          (NP
            (NP (NN recruitment))
            (PP (IN of)
              (NP (NN pDCs)))
            (PP (IN into)
              (NP (DT the) (JJ inflamed)
                (ADJP (NN RA) (JJ synovial))
                (NN environment))))
          (CC and)
          (NP
            (NP (PRP$ their) (NN contribution))
            (PP (IN as)
              (NP
                (NP
                  (NP (JJ antigen-presenting) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NNS APCs))
                    (-RRB- -RRB-)))
                (CC and)
                (NP (JJ inflammatory) (NNS cells))))
            (PP (IN in)
              (NP (NN RA)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ CD11c+) (JJ myeloid) (NNS DCs))
        (CC and)
        (NP (JJ CD123+) (NNS pDCs)))
      (VP
        (VP (VBD were)
          (VP (VBN compared)
            (PP (IN in)
              (NP
                (NP
                  (NP
                    (ADJP (JJ normal)))
                  (CC and)
                  (NP (NN RA))
                  (NP (NN PB)))
                (, ,)
                (NP
                  (NP (JJ synovial) (NN fluid))
                  (PRN (-LRB- -LRB-)
                    (NP (NN SF))
                    (-RRB- -RRB-)))
                (, ,)
                (CC and)
                (NP (JJ synovial) (NN tissue))))
            (PP (IN by)
              (NP
                (NP (NN flow) (NN cytometry))
                (, ,)
                (NP (NN immunohistochemistry))
                (, ,)
                (CC and)
                (NP (NN electron) (NN microscopy))))))
        (CC and)
        (VP (VBD were)
          (VP (VBN sorted)
            (PP (IN for)
              (NP (JJ functional) (NNS studies)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Nuclear) (NN RelB-CD123+) (NNS DCs))
      (VP (VBD were)
        (ADJP (JJ located)
          (PP
            (PP (IN in)
              (NP
                (NP (JJ perivascular) (NNS regions))
                (PP (IN of)
                  (NP (NN RA)))))
            (, ,)
            (PP (IN in)
              (NP
                (NP (DT a) (JJ similar) (NN frequency))
                (PP (TO to)
                  (NP (JJ nuclear) (JJ RelB+CD123-) (NNS DCs)))))
            (, ,)
            (CC but)
            (RB not)
            (NP (JJ normal) (JJ synovial) (NN tissue) (JJ sublining))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Apart)
        (PP (IN from)
          (NP
            (NP (JJR higher) (NN expression))
            (PP (IN of)
              (NP (NN HLA-DR))))))
      (, ,)
      (NP
        (NP (DT the)
          (NP (NNS numbers))
          (CC and)
          (NP (NNS phenotypes)))
        (PP (IN of)
          (NP (NN SF) (NNS pDCs))))
      (VP (VBD were)
        (ADJP (JJ similar)
          (PP (TO to)
            (NP
              (NP (DT those))
              (PP (IN of)
                (NP (JJ normal) (NN PB) (NNS pDCs))))))))
    (. .)))

(
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (NN APC) (NN function))
          (PP (IN of)
            (NP (NN PB) (NNS pDCs))))
        (VP (VBD was)
          (ADJP (RBR less) (JJ efficient)
            (PP (IN than)
              (NP
                (NP (DT that))
                (PP (IN of)
                  (NP (NN PB) (JJ myeloid) (NNS DCs)))))))))
    (, ,)
    (S
      (S
        (NP (NN RA) (NN SF) (NNS pDCs))
        (VP
          (ADVP (RB efficiently))
          (VBN activated)
          (S
            (VP (VBG resting)
              (NP (JJ allogeneic) (NN PB) (NN T) (NNS cells))))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (JJ high) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NN IFN-γ))
              (, ,)
              (NP (NN IL-10))
              (, ,)
              (CC and)
              (NP (NN tumor) (NN necrosis) (NN factor) (CD α)))))
        (VP (VBD were)
          (VP (VBN produced)
            (PP (IN in) (NN response) (TO to)
              (NP
                (NP (NN incubation))
                (PP (IN of)
                  (NP (JJ allogeneic) (NN T) (NNS cells)))
                (PP (IN with)
                  (NP
                    (NP (DT either) (NN type))
                    (PP (IN of)
                      (NP (NN SF) (NNS DCs))))))))))
      (. .))))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (NNS pDCs))
      (VP
        (VP (VBP are)
          (VP (VBN recruited)
            (PP (TO to)
              (NP (NN RA) (JJ synovial) (NN tissue)))))
        (CC and)
        (VP (VBP comprise)
          (NP
            (NP (DT an) (NN APC) (NN population))
            (ADJP (JJ distinct)
              (PP (IN from)
                (NP (DT the)
                  (ADJP (RB previously) (VBN described))
                  (JJ nuclear) (NN RelB+) (JJ synovial) (NNS DCs))))))))
    (. .)))

(
  (S
    (S
      (NP (NN pDCs))
      (VP (MD may)
        (VP (VB contribute)
          (ADVP (RB significantly))
          (PP (TO to)
            (NP (DT the) (JJ local) (JJ inflammatory) (NN environment))))))
    (. .)))

(
  (S
    (NP (NN Introduction))))

(
  (S
    (S
      (NP
        (NP (NN Plasmacytoid) (JJ dendritic) (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP (NNS pDCs))
          (-RRB- -RRB-)))
      (VP (VBP are)
        (NP
          (NP (DT a) (JJ distinct) (NN population))
          (PP (IN of)
            (NP
              (NP
                (NP (JJ antigen-presenting) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NNS APCs))
                  (-RRB- -RRB-)))
              (PP (IN with)
                (NP
                  (NP (DT the) (NN capacity))
                  (PP (IN for)
                    (NP
                      (NP (JJ potent) (JJ antigen-presenting) (NN function))
                      (CC and)
                      (NP
                        (NP (NN production))
                        (PP (IN of)
                          (NP
                            (NP (JJ large) (NNS amounts))
                            (PP (IN of)
                              (NP
                                (NP (NNS cytokines))
                                (, ,)
                                (PP (VBG including)
                                  (NP
                                    (NP
                                      (NP
                                        (NP (NN tumor) (NN necrosis) (NN factor))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NN TNF))
                                          (-RRB- -RRB-)))
                                      (NN -α))
                                    (CC and)
                                    (NP (NN IFN-α))))))))))))))))))
    (. .)))

(
  (S
    (NP (JJ Human) (NNS pDCs))
    (VP (MD can)
      (VP (VB be)
        (VP (VBN identified)
          (PP (IN by)
            (NP
              (NP
                (NP (JJ cell-surface) (NN expression))
                (PP (IN of)
                  (NP (NN MHC) (NNS molecules))))
              (, ,)
              (NP
                (NP (DT the) (NN α-chain))
                (PP (IN of)
                  (NP (DT the)
                    (NP
                      (NP (NN IL-3) (NN receptor))
                      (PRN (-LRB- -LRB-)
                        (NP (NN CD123))
                        (-RRB- -RRB-))))))
              (, ,)
              (CC and)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP
                    (NP
                      (NP
                        (NP (NN blood) (NN dendritic-cell))
                        (PRN (-LRB- -LRB-)
                          (NP (NN DC))
                          (-RRB- -RRB-)))
                      (NNS antigens))
                    (VP (VBN known)
                      (PP (IN as)
                        (NP
                          (NP (NN BDCA2))
                          (CC and)
                          (NP (NN BDCA4))))))))))
          (PP (IN in)
            (NP
              (NP (DT a) (NN proportion))
              (PP (IN of)
                (NP
                  (NP (NNS cells))
                  (PRN (NN -LSB-1) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN comparison))
          (PP (IN with)
            (NP (JJ CD11c+) (JJ myeloid) (NNS DCs)))))
      (, ,)
      (NP (NNS pDCs))
      (VP (VBP display)
        (NP
          (NP
            (NP (DT a) (JJ distinct) (NN set))
            (PP (IN of)
              (NP (NN chemokine))))
          (CC and)
          (NP (JJ Toll-like) (NNS receptors))
          (NP (NN -LSB-2-4))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (PP (IN In) (NN response) (TO to)
        (NP
          (NP (NNS viruses))
          (CC and)
          (NP (NN CpG) (NN DNA))))
      (, ,)
      (S
        (NP (NNS pDCs))
        (VP (VBP become)
          (VP (VBN activated)
            (S
              (VP (TO to)
                (VP (VB produce)
                  (NP (NN IFN-α))))))))
      (CC and)
      (S
        (NP (PRP$ their) (NN APC) (NN function))
        (VP (VBZ is)
          (VP (VBN enhanced)
            (NP (CD -LSB-5-8) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN While)
        (S
          (NP (NNS pDCs))
          (VP (VBD were)
            (ADVP (RB first))
            (VP (VBN demonstrated)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN T-cell) (NNS areas))
                  (PP (IN of)
                    (NP (NN lymph) (NNS nodes) (CD -LSB-5,9) (-RRB- -RSB-)))))))))
      (, ,)
      (NP
        (NP (NNS precursors))
        (PP (IN of)
          (NP (DT this) (NN DC) (NN population))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN isolated)
            (PP (IN from)
              (NP
                (NP (JJ several) (NNS sources))
                (, ,)
                (PP (VBG including)
                  (NP
                    (NP
                      (NP (JJ normal) (JJ peripheral) (NN blood))
                      (PRN (-LRB- -LRB-)
                        (NP (NN PB))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP (NN thymus))
                    (, ,)
                    (NP (JJ fetal) (NN liver))
                    (, ,)
                    (CC and)
                    (NP (NN bone) (NN marrow) (CD -LSB-10)))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP (PRP they))
        (VP (VBP do) (RB not)
          (VP (VB reside)
            (PP (IN in)
              (NP (JJ normal) (JJ peripheral) (NNS tissues)))))))
    (, ,)
    (S
      (NP (NNS pDCs))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (NN infiltrate)
                  (NP
                    (NP
                      (NP (JJ certain) (JJ inflamed) (NNS tissues))
                      (CC and)
                      (NP (NN tumor) (NNS sites)))
                    (, ,)
                    (PP (VBG including)
                      (NP
                        (NP
                          (NP (DT the) (NN skin))
                          (PP (IN in)
                            (NP
                              (NP (NN psoriasis))
                              (CC and)
                              (NP (NN lupus)))))
                        (, ,)
                        (NP
                          (NP (DT the) (JJ cerebrospinal) (NN fluid))
                          (PP (IN in)
                            (NP (JJ multiple) (NN sclerosis))))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (NN melanoma))
                          (CC and)
                          (NP (JJ ovarian) (NN carcinoma) (CD -LSB-11-15)))
                        (-RRB- -RSB-))))))))))
      (. .))))

(
  (S
    (S
      (SBAR (IN While)
        (S
          (NP (NNS pDCs))
          (VP (VBP play)
            (NP (DT an) (JJ important) (NN effector) (NN role))
            (PP (IN in)
              (NP (JJ viral) (NN disease)))
            (, ,)
            (S
              (VP
                (VP (VBG being)
                  (NP
                    (NP (DT the) (JJ major) (NNS producers))
                    (PP (IN of)
                      (NP (NN IFN-α)))))
                (CC and)
                (VP (VBG having)
                  (NP
                    (NP (DT a) (JJ primary) (NN role))
                    (PP (IN in)
                      (NP (JJ innate) (NN immunity))))))))))
      (, ,)
      (NP (EX there))
      (VP (VBZ is)
        (ADVP (RB also))
        (NP (NN evidence)
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (MD may)
                (VP (VB play)
                  (NP (DT an) (JJ immunoregulatory) (NN role)))))))
        (, ,)
        (PP (IN through)
          (NP
            (NP (DT the) (NN induction))
            (PP (IN of)
              (NP
                (NP (NN Th2) (-LRB- -LRB-)
                  (NP (NN T) (NN helper) (CD 2))
                  (-RRB- -RRB-) (JJ -type) (NNS cytokines))
                (CD -LSB-9,16-18) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ synovial) (JJ autoimmune) (NN reaction))
        (PP (IN of)
          (NP
            (NP (JJ rheumatoid) (NN arthritis))
            (PRN (-LRB- -LRB-)
              (NP (NN RA))
              (-RRB- -RRB-)))))
      (VP (VBZ is)
        (VP (VBN characterized)
          (PP (IN by)
            (NP
              (NP (NN lymphocyte) (, ,) (NN macrophage) (, ,)
                (CC and)
                (NN DC) (NN infiltration))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (MD can)
                    (VP (VB progress)
                      (PP (TO to)
                        (NP
                          (NP (DT the) (NN development))
                          (PP (IN of)
                            (NP (JJ lymphoid) (NN tissue)))
                          (PP (IN in)
                            (NP (JJ established) (NN disease) (NN -LSB-19-21)))
                          (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS DCs))
      (VP (VBP are)
        (ADJP (JJ likely)
          (S
            (VP (TO to)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the)
                      (NP (NN formation))
                      (CC and)
                      (NP (NN maintenance)))
                    (PP (IN of)
                      (NP
                        (NP (PDT such) (VBN organized) (JJ lymphoid) (NN tissue))
                        (CC and)
                        (NP (NN antigen) (NN presentation))))
                    (PP (IN in)
                      (NP
                        (NP (NN RA))
                        (CC and)
                        (NP (JJ other)
                          (NP (JJ autoimmune) (NNS lesions))
                          (CD -LSB-22-24) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBP have)
      (ADVP (RB previously))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN effector) (NN site))
              (PP (IN in)
                (NP (NN RA) (JJ synovial) (NN tissue))))
            (VP (VBZ is)
              (VP (VBN enriched)
                (PP (IN in)
                  (NP
                    (NP (VBN differentiated) (JJ myeloid) (NNS DCs))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP express)
                          (NP
                            (NP (NN CD33))
                            (, ,)
                            (NP (NN CD11c))
                            (, ,)
                            (NP (NN MHC)
                              (CC and)
                              (JJ costimulatory) (NNS molecules))
                            (, ,)
                            (CC and)
                            (NP (JJ nuclear) (NN RelB) (NN -LSB-21,25))))
                        (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Translocation))
        (PP (IN of)
          (NP (NN RelB)))
        (PP (TO to)
          (NP
            (NP (DT the) (NN nucleus))
            (PP (IN of)
              (NP (JJ myeloid) (NNS DCs))))))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP (NN APC) (NN function)))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN through)
            (NP
              (NP (VBN increased) (NN expression))
              (PP (IN of)
                (NP (NN MHC) (NNS molecules)
                  (NP
                    (NP (NN CD86))
                    (CC and)
                    (NP (NN CD40) (NN -LSB-26)))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ proinflammatory) (NNS cytokines))
        (NP
          (NP (NN TNF-α))
          (CC and)
          (NP (NN IL-1β))))
      (VP (VBP are)
        (NP
          (NP (JJ key) (NNS contributors))
          (PP (TO to)
            (NP
              (NP (DT the) (JJ inflammatory) (NN cytokine) (NN cascade))
              (PP (IN in)
                (NP (NN RA) (CD -LSB-27,28)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT This))
        (VP (VBZ relates)
          (PP (TO to)
            (NP
              (NP (DT a) (NN number))
              (PP (IN of)
                (NP (NNS actions)))))))
      (, ,)
      (CC but)
      (S
        (NP
          (NP (NN activation))
          (PP (IN of)
            (NP (DT the) (NN endothelium)))
          (PP (IN by)
            (NP (NN TNF-α))))
        (VP (VBZ is)
          (ADJP (RB particularly) (JJ important)
            (PP (IN in)
              (NP
                (NP (JJ cellular) (NN recruitment))
                (PP (TO to)
                  (NP (DT the) (NN synovium) (CD -LSB-29-31) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP (NN RA))
          (VP (VBZ is)
            (VP (VBN characterized)
              (PP (IN by)
                (NP
                  (NP (JJ endothelial) (NN activation))
                  (, ,)
                  (NP (NN leukocyte) (NN recruitment))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (JJ high) (JJ endothelial) (NNS venules))))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD hypothesized)
        (SBAR (IN that)
          (S
            (NP (NNS pDCs))
            (VP (MD would)
              (VP (VB be)
                (VP (VBN enriched)
                  (PP (IN in)
                    (NP
                      (ADJP
                        (ADJP (JJ inflamed))
                        (CONJP (CC but)
                          (RB not))
                        (ADJP (JJ normal)))
                      (NN synovium))))))))))
    (. .)))

(
  (S
    (SBAR (IN Since)
      (S
        (NP
          (NP (DT the) (JJ functional) (NN role))
          (PP (IN of)
            (NP (NN pDCs)))
          (PP (IN in)
            (NP (NN disease) (NN pathogenesis))))
        (VP (VBZ is)
          (ADVP (RB only) (RB partly))
          (VP (VBN understood)))))
    (, ,)
    (NP (PRP we))
    (ADVP (RB also))
    (VP (VBD wished)
      (S
        (VP (TO to)
          (VP (VB address)
            (SBAR
              (SBAR (IN whether)
                (S
                  (NP (DT these) (NNS cells))
                  (VP (VBP represent)
                    (NP
                      (NP (DT a) (NN population))
                      (ADJP (JJ distinct)
                        (PP (IN from)
                          (NP (DT the) (VBN described) (JJ nuclear) (NN RelB+) (JJ synovial) (NNS DCs))))))))
              (, ,)
              (CC and)
              (SBAR (IN whether)
                (S
                  (NP (PRP they))
                  (VP (MD may)
                    (VP (VB contribute)
                      (PP (IN as)
                        (NP
                          (NP (NNS APCs))
                          (CC or)
                          (NP (JJ inflammatory) (NNS cells))))
                      (PP (IN in)
                        (NP (NN RA) (CD -LSB-21) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Materials))
      (CC and)
      (NP (NNS methods)))))

(
  (S
    (S
      (NP
        (NP (CD Thirty) (NNS patients))
        (SBAR
          (WHNP (WP who))
          (S
            (VP (VBD fulfilled)
              (NP
                (NP (DT the)
                  (NP
                    (NP (NNP American) (NN College))
                    (PP (IN of)
                      (NP (NN Rheumatology))))
                  (NNS criteria))
                (PP (IN for)
                  (NP (NN RA))))))))
      (VP (VBD were)
        (VP (VBN included)
          (NP (CD -LSB-32) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (PP (IN Of)
        (NP (DT these)))
      (, ,)
      (S
        (NP (CD 10))
        (VP (VBD provided)
          (NP
            (NP
              (NP (JJ synovial) (NN fluid))
              (PRN (-LRB- -LRB-)
                (NP (NN SF))
                (-RRB- -RRB-)))
            (NNS samples))))
      (CC and)
      (S
        (NP (CD 27))
        (VP (VBD provided)
          (NP (NN PB) (NNS samples)))))
    (. .)))

(
  (S
    (S
      (PP (IN Of)
        (NP (DT the) (CD 30) (NNS patients)))
      (, ,)
      (S
        (NP (CD 80) (NN %))
        (VP (VBD were)
          (ADJP (JJ seropositive))))
      (, ,)
      (S
        (NP (CD 62) (NN %))
        (VP (VBD were)
          (NP (NN female))))
      (, ,)
      (CC and)
      (S
        (NP (CD 73) (NN %))
        (VP (VBD were)
          (VP (VBG taking)
            (NP
              (NP
                (QP (IN at) (JJS least) (CD one))
                (JJ disease-modifying) (NN antirheumatic) (NN drug))
              (CC or)
              (NP
                (NP (JJ low-dose) (NN prednisone))
                (CC or)
                (NP (DT both))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Synovial) (NN tissue))
      (VP (VBD was)
        (VP (VBN obtained)
          (PP (IN at)
            (NP (NN arthroscopy)))
          (PP (IN from)
            (NP
              (NP (CD seven) (NNS patients))
              (PP (IN with)
                (NP (NN RA)))))
          (, ,)
          (SBAR
            (WHPP (IN of)
              (WHNP (WP whom)))
            (S
              (S
                (NP (CD three))
                (VP (VBD were)
                  (ADJP (JJ untreated))))
              (CC and)
              (S
                (NP (CD four))
                (VP (VBD were)
                  (VP (VBG taking)
                    (NP
                      (NP
                        (QP (IN at) (JJS least) (CD one))
                        (JJ disease-modifying) (NN antirheumatic) (NN drug))
                      (CC and)
                      (NP (JJ low-dose) (NN prednisone)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN duration))
        (PP (IN of)
          (NP (NN disease))))
      (VP (VBD ranged)
        (PP (IN from)
          (NP
            (QP (CD 0.5) (TO to) (CD 18))
            (NNS years)))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD studied)
      (NP
        (NP (JJ synovial) (NN tissue))
        (PP (IN from)
          (NP
            (NP (CD four) (JJ healthy) (NNS individuals))
            (PP (IN with)
              (NP
                (NP (JJ nonspecific) (NN knee) (NN pain))
                (VP (VBG undergoing)
                  (NP
                    (NP (NN arthroscopy))
                    (, ,)
                    (NP
                      (NP (CD one) (NN patient))
                      (SBAR
                        (WHNP (WP who))
                        (S
                          (VP (VBD had)
                            (VP (VBD had)
                              (NP
                                (NP (JJ psoriatic) (NN arthritis))
                                (PP (IN for)
                                  (NP (CD 8) (NNS years)))))))))
                    (, ,)
                    (CC and)
                    (NP
                      (NP (CD one) (NN patient))
                      (SBAR
                        (WHNP (WP who))
                        (S
                          (VP (VBD had)
                            (VP (VBD had)
                              (NP
                                (NP (JJ ankylosing) (NNS spondylitis))
                                (PP (IN for)
                                  (NP (CD 30) (NNS years)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT Each) (NN patient))
        (PP (IN with)
          (NP (NN spondyloarthropathy))))
      (VP (VBD was)
        (VP (VBG taking)
          (NP (NN sulfasalazine)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT No) (NN patient))
        (PP (IN in)
          (NP (DT the) (NN study))))
      (VP (VBD was)
        (VP (VBG taking)
          (NP (NN biologics)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Synovial) (NN tissue))
      (VP (VBD was)
        (VP (VBN provided)
          (PP (IN by)
            (NP
              (NP (NN Dr) (NNP Malcolm) (NNP Smith))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Repatriation) (NNP Hospital))
                  (, ,)
                  (NP (NN Adelaide))
                  (, ,)
                  (NP (NNP Australia)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN PB) (JJ buffy) (NNS coats))
        (VP (VBN prepared)
          (PP (IN from)
            (NP (CD 30) (JJ healthy) (NNS donors)))))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN from)
            (NP
              (NP
                (NP (DT the) (JJ Red) (NN Cross) (NN Blood) (NN Transfusion))
                (NN Service))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Brisbane) (, ,) (NNP QLD))
                  (, ,)
                  (NP (NNP Australia)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN study))
      (VP (VBD was)
        (ADJP (JJ approved)
          (PP (IN by)
            (NP
              (NP (DT the) (NN Research) (NN Ethics) (NN Committee))
              (PP (IN of)
                (NP (DT the) (NN Princess) (NN Alexandra) (NN Hospital))))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP
              (NP
                (NP (NN RPMI) (CD 1640))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Gibco))
                    (, ,)
                    (NP (NN Life) (NNS Technologies))
                    (, ,)
                    (NP (NNP Mulgrave) (, ,) (NN VIC) (, ,) (NNP Australia)))
                  (-RRB- -RRB-)))
              (VP (VBN supplemented)
                (PP (IN with)
                  (NP
                    (NP
                      (NP
                        (ADJP (CD 10) (NN %))
                        (NN FCS))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (NN CSL))
                          (NP
                            (NP (NNP Ltd) (, ,) (NNP Parkville))
                            (, ,)
                            (NP (NN VIC))
                            (, ,)
                            (NP (NNP Australia))))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (CD 0.3) (NN mg/ml) (NN L-glutamine))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Trace) (NNP Biosciences) (, ,) (NNP Castle) (NNP Hill) (, ,) (NNP NSW) (, ,) (NNP Australia))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NP
                      (NP (NN 0.12) (NN mg/ml) (NN benzylpenicillin))
                      (PRN (-LRB- -LRB-)
                        (NP (NN CSL))
                        (-RRB- -RRB-)))
                    (, ,)
                    (CC and)
                    (NP
                      (NP
                        (ADJP (CD 10) (NN μg/ml))
                        (NN gentamicin))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP
                            (NP (NN Delta) (NNP West) (, ,) (NNP Pharmacia))
                            (CC and)
                            (NP (NNP Upjohn)))
                          (, ,)
                          (NP (NN Spring) (NN Hill))
                          (, ,)
                          (NP (NNP QLD) (, ,) (NNP Australia)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ monoclonal) (NNS antibodies))
        (VP (VBN used)
          (PP (IN in)
            (NP (DT this) (NN study)))))
      (VP (VBP include)
        (NP
          (NP (NN FITC))
          (, ,)
          (NP
            (NP (NN phycoerythrin))
            (PRN (-LRB- -LRB-)
              (NP (NN PE))
              (-RRB- -RRB-)))
          (, ,)
          (CC and)
          (NP
            (NP (VBN purified) (NN anti-CD11c))
            (PRN (, ,)
              (NP
                (NP (NN CD14-PerCP))
                (, ,)
                (NP
                  (NP (NN PE))
                  (, ,)
                  (VP
                    (VP
                      (VP (VBN biotinylated))
                      (CC and)
                      (VP (VBN purified)
                        (NP
                          (NP (NN anti-CD123))
                          (, ,)
                          (NP
                            (NP (NN CD86-FITC))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (NN all))
                                (PP (IN from)
                                  (NP (NNP BD) (NNP Pharmingen) (, ,) (NNP San) (NNP Diego) (, ,) (NN CA) (, ,) (NN USA) (-RRB- -RRB-) (, ,)
                                    (NP
                                      (NP
                                        (NP (NN BDCA2-FITC))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NNP Miltenyi) (NNP Biotech) (, ,) (NNP San) (NNP Francisco) (, ,)
                                            (NP (NN CA))
                                            (, ,)
                                            (NP (NNP USA)))
                                          (-RRB- -RRB-)))
                                      (, ,)
                                      (NP
                                        (NP (NN HLA-DR-biotin))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NNP Coulter) (NNP Immunotech) (, ,) (NNP Fullerton) (, ,)
                                            (NP (NN CA))
                                            (, ,)
                                            (NP (NNP USA)))
                                          (-RRB- -RRB-)))
                                      (, ,)
                                      (NP
                                        (NP (NN CD40-FITC))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NNP Biolegend) (, ,) (NNP San) (NNP Diego) (, ,)
                                            (NP (NN CA))
                                            (, ,)
                                            (NP (NNP USA)))
                                          (-RRB- -RRB-)))
                                      (, ,)
                                      (NP
                                        (NP (NN CD80-FITC))
                                        (PRN (-LRB- -LRB-)
                                          (NP
                                            (NP (NNP Cymbus) (NNP Biotech) (, ,) (NNP Chandlers) (NNP Ford))
                                            (, ,)
                                            (NP (NNP Hants) (, ,) (NNP UK)))
                                          (-RRB- -RRB-)))
                                      (, ,)
                                      (NP (NN CD68) (-LRB- -LRB-) (NN Kp-1) (, ,) (NN DAKO) (, ,) (NNP Carpinteria))
                                      (, ,)
                                      (NP (NN CA))
                                      (, ,))
                                    (NN USA))))
                              (-RRB- -RRB-)))
                          (, ,)
                          (NP
                            (NP (NN RelB))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (NN C-19))
                                (, ,)
                                (NP (NNP Santa) (NNP Cruz) (NNP Biotech) (, ,) (NNP Santa) (NNP Cruz))
                                (, ,)
                                (NP (NN CA))
                                (, ,)
                                (NP (NN USA)))
                              (-RRB- -RRB-)))
                          (, ,)
                          (CC and)
                          (NP (VBN biotinylated) (NN Ulex) (NN europaeus) (NN agglutinin) (CD I)))))
                    (-LRB- -LRB-)
                    (NP (NN Vector) (NNS Laboratories))))
                (, ,)
                (NP (NNP Burlingame) (, ,) (NN CA) (, ,) (NNP USA)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (NP (JJ Mononuclear) (NNS cells))
    (VP (VBD were)
      (VP (VBN prepared)
        (PP (IN from)
          (NP (JJ normal)
            (CC or)
            (NN RA) (NN PB)
            (CC or)
            (NN RA) (NN SF)))
        (PP (IN by)
          (NP
            (NP (NN density) (NN gradient) (NN centrifugation))
            (PP (IN over)
              (NP
                (NP (NN Ficoll-Paque))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Pharmacia) (NNP Biotech) (, ,) (NNP Uppsala) (, ,) (NNP Sweden))
                  (-RRB- -RRB-))))))
        (PP (IN as)
          (NP (VBN described) (NN elsewhere) (CD -LSB-33) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN T) (NNS cells))
      (VP (VBD were)
        (VP (VBN purified)
          (PP (IN from)
            (NP (NN PB) (JJ mononuclear) (NNS cells)))
          (PP (IN by)
            (S
              (VP (VBG passing)
                (NP (DT the) (NNS cells))
                (PP (IN over)
                  (NP
                    (NP (DT a) (NN nylon) (NN wool) (NN column))
                    (, ,)
                    (VP (VBN followed)
                      (PP (IN by)
                        (NP
                          (NP (JJ immunomagnetic) (NN depletion))
                          (PP (IN of)
                            (NP
                              (NP (VBG remaining) (NNS monocytes))
                              (, ,)
                              (NP (NNS DCs))
                              (, ,)
                              (NP (NN B) (NNS cells))
                              (, ,)
                              (CC and)
                              (NP (NN NK)
                                (PRN (-LRB- -LRB-)
                                  (NP (JJ natural) (NN killer))
                                  (-RRB- -RRB-))
                                (NNS cells))))))
                      (S
                        (VP (VBG using)
                          (NP
                            (NP (JJ monoclonal) (NNS antibodies))
                            (PP (IN against)
                              (NP
                                (NP (NN CD14))
                                (, ,)
                                (NP (NN CD16))
                                (, ,)
                                (NP (NN CD19))
                                (, ,)
                                (NP (NN CD56))
                                (, ,)
                                (CC and)
                                (NP
                                  (NP (NN HLA-DR))
                                  (PRN (-LRB- -LRB-)
                                    (NP
                                      (NP (NN all))
                                      (PP (IN from)
                                        (NP (NNP BD) (NNP Pharmingen))))
                                    (-RRB- -RRB-)))))))))
                    (, ,)
                    (VP (VBN followed)
                      (PP (IN by)
                        (NP
                          (NP (NN goat) (NN antimouse) (NN immunoglobulin) (JJ magnetic) (NNS beads))
                          (, ,)
                          (ADVP (RB then))
                          (NP
                            (NP
                              (NP (NN passage))
                              (PP (IN through)
                                (NP
                                  (NP (DT a) (JJ strong) (JJ magnetic) (NN field))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NN MACS) (, ,) (NNP Miltenyi) (NNP Biotech))
                                    (-RRB- -RRB-)))))
                            (, ,)
                            (CC and)
                            (NP
                              (NP (NN collection))
                              (PP (IN of)
                                (NP (DT the) (JJ unbound) (NN fraction))))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN On)
        (NP
          (NP (NN analysis))
          (PP (IN by)
            (NP (NN flow) (NN cytometry)))))
      (, ,)
      (NP (DT the) (JJ unbound) (NN fraction))
      (ADVP (RB routinely))
      (VP (VBD contained)
        (NP
          (ADJP (CD 95–98) (NN %))
          (JJ CD3+) (NN T) (NNS cells))))
    (. .)))

(
  (S
    (S
      (NP (JJ DC-enriched) (JJ non-T) (NNS cells))
      (VP (VBD were)
        (VP (VBN produced)
          (PP (IN by)
            (NP
              (NP (JJ immunomagnetic) (NN depletion))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (NP (NN T))
                      (, ,)
                      (NP (NN B))
                      (, ,)
                      (CC and)
                      (NP (NN NK)))
                    (NNS cells))
                  (PP (IN from)
                    (NP (JJ non-T) (NNS cells)))))))
          (, ,)
          (PP (IN by)
            (NP
              (NP (NN incubation))
              (PP (IN with)
                (NP
                  (NP (JJ monoclonal) (NNS antibodies))
                  (PP (IN against)
                    (NP
                      (NP (NN CD19))
                      (, ,)
                      (NP (NN CD16))
                      (, ,)
                      (NP (NN CD56))
                      (, ,)
                      (CC and)
                      (NP (NN CD3)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB enumerate)
            (NP
              (NP
                (ADJP
                  (ADJP (JJ CD123+))
                  (CC and)
                  (ADJP (JJ CD11c+)))
                (NNS subsets))
              (PP (IN of)
                (NP (NN DCs)))))))
      (, ,)
      (NP
        (NP (JJ mononuclear) (NNS cells))
        (PP (IN from)
          (NP
            (NP (JJ normal) (NN PB))
            (CC or)
            (NP (NN RA) (NN SF)))))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN for)
            (NP (JJ four-colour) (NN flow) (NN cytometry))))
        (SBAR (IN as)
          (S
            (VP (VBN described)
              (NP (NN elsewhere) (CD -LSB-33) (-RRB- -RSB-))
              (, ,)
              (S
                (VP (VBG using)
                  (NP
                    (NP (JJ monoclonal) (NNS antibodies))
                    (PP (IN against)
                      (NP
                        (NP (NN CD14-PECy5))
                        (, ,)
                        (NP (NN CD11c-FITC))
                        (, ,)
                        (NP (NN CD123-PE))
                        (, ,)
                        (CC and)
                        (NP (NN HLA-DR-APC))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Live) (JJ CD14-HLA-DR+) (JJ mononuclear) (NNS cells))
      (VP (VBD were)
        (VP (VBN gated)
          (PP (IN for)
            (NP (NN analysis))))))
    (. .)))

(
  (S
    (S
      (NP (NN Subset) (NNS percentages))
      (VP (VBP are)
        (VP (VBN expressed)
          (PP (IN as)
            (NP
              (NP (NN percentage))
              (PP (IN of)
                (NP (JJ total) (JJ mononuclear) (NNS cells))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Listmode) (NNS data))
      (VP (VBD were)
        (VP (VBN analyzed)
          (S
            (VP (VBG using)
              (NP (NN Winlist) (CD 2.0) (NN software))))
          (PRN (-LRB- -LRB-)
            (NP (NN Verity) (NN Software) (NN House))
            (, ,)
            (NP
              (NP (NNP Topsham))
              (, ,)
              (NP (NNP ME) (, ,) (NNP USA)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN sorting)))
      (, ,)
      (NP
        (NP (NN PB)
          (CC or)
          (NN SF) (JJ DC-enriched) (JJ non-T) (NNS cells))
        (VP (VBN stained)
          (PP (IN with)
            (NP (DT the) (JJ same) (CD four) (NNS markers)))))
      (VP (VBD were)
        (VP (VBN sorted)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (NN Moflo) (NN flow) (NN cytometer))
                (PRN (-LRB- -LRB-)
                  (NP (NN DAKO))
                  (-RRB- -RRB-)))
              (, ,)
              (PP (VBG gating)
                (PP (IN on)
                  (NP
                    (ADJP
                      (ADJP (JJ CD14-HLA-DR+))
                      (CC and)
                      (ADJP (CC either)
                        (ADJP (JJ CD123+CD11c-))
                        (CC or)
                        (ADJP (JJ CD11c+CD123-))))
                    (NNS cells))))
              (, ,)
              (ADVP (RB respectively)))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJ phenotypic) (NN analysis)))
      (, ,)
      (NP
        (NP (JJ mononuclear) (NNS cells))
        (PP (IN from)
          (NP
            (NP (NN PB))
            (CC or)
            (NP (NN SF)))))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NN CD14-PECy5))
              (, ,)
              (NP
                (NP (NN CD123-PE))
                (CC or)
                (NP (NN CD11c-PE)))
              (, ,)
              (NP (NN HLA-DR-APC))
              (, ,)
              (CC and)
              (NP
                (NP (CC either)
                  (NP (DT a) (JJ fourth) (JJ monoclonal) (NN antibody))
                  (CC or)
                  (NP (NN isotype) (NN control))
                  (NP (JJ monoclonal) (NN antibody)))
                (VP (VBN conjugated)
                  (PP (IN with)
                    (NP (NN FITC))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS DCs))
      (VP (VBD were)
        (VP (VBN gated)
          (SBAR (IN as)
            (S
              (VP (VBN described)
                (ADVP (RB above))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Electron) (NN microscopy))
        (PP (IN of)
          (NP
            (ADJP (RB freshly) (VBN sorted))
            (NNS cells))))
      (VP (VBD was)
        (VP (VBN carried)
          (PRT (RP out))
          (PP (IN as)
            (NP (VBN described) (NN elsewhere) (CD -LSB-5)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN fixation))
          (PP (IN in)
            (NP
              (NP
                (ADJP (CD 2.5) (NN %))
                (NN glutaraldehyde))
              (PP (IN in)
                (NP (JJ phosphate-buffered) (NN saline)))))))
      (, ,)
      (NP (DT the) (NNS cells))
      (VP (VBD were)
        (ADJP (JJ post-fixed)
          (PP (IN with)
            (NP
              (NP (DT an) (JJ aqueous) (NN solution))
              (PP (IN of)
                (NP
                  (NP
                    (ADJP (CD 1) (NN %))
                    (NN OsO4))
                  (VP (VBG containing)
                    (NP
                      (ADJP (CD 1.5) (NN %))
                      (NN K4Fe) (-LRB- -LRB-) (NN CN) (-RRB- -RRB-) (CD 6))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Subsequently))
      (, ,)
      (NP (DT the) (NNS specimens))
      (VP (VBD were)
        (VP
          (VP (VBN dehydrated)
            (PP (IN in)
              (NP (DT an) (NN alcohol) (NN series))))
          (CC and)
          (ADJP (JJ embedded)
            (PP (IN into)
              (NP (NN epon)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Ultrathin) (NNS sections))
        (PRN (-LRB- -LRB-)
          (NP (CD 50) (NN nm))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP
          (VP (VBN contrasted)
            (PP (IN with)
              (NP
                (NP (NN lead) (NN citrate))
                (CC and)
                (NP (NN uranyl) (NN acetate)))))
          (CC and)
          (VP (VBN studied)
            (PP (IN with)
              (NP
                (NP (DT a) (NN CM100) (NN electron) (NN microscope))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN Philips))
                    (, ,)
                    (NP (NNP Eindhoven) (, ,) (NNP The) (NNP Netherlands)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Various) (NNS numbers))
        (PP (IN of)
          (NP
            (NP (VBN sorted) (NN PB))
            (CC or)
            (NP (NN RA) (NN SF) (NNS DCs)))))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP (CD 105) (JJ allogeneic) (NN PB) (NN T) (NNS cells))
              (PP (IN in)
                (NP (JJ triplicate) (NNS wells)))))
          (PP (IN for)
            (NP (CD 5) (NNS days))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN described)
              (NP (NN elsewhere) (CD -LSB-33) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Supernatants))
        (VP (VBD were)
          (VP (VBN removed)
            (PP (IN from)
              (NP (DT some) (NNS cultures))))))
      (CC and)
      (S
        (NP
          (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 1) (NN μCi/well))
              (, ,)
              (NP (NN ICN) (NN Biochemicals)))
            (-RRB- -RRB-)))
        (VP (VBD was)
          (VP (VBN added)
            (PP (TO to)
              (NP
                (NP (DT the) (NN remainder))
                (PP (IN for)
                  (NP (DT the) (JJ final) (CD 18) (NN h)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Cells))
        (VP (VBD were)
          (VP (VBN harvested)
            (PP (IN onto)
              (NP (JJ glass-fiber) (NN filter) (NNS mats))))))
      (CC and)
      (S
        (NP
          (NP (DT the) (NN incorporation))
          (PP (IN of)
            (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine))))
        (VP (VBD was)
          (VP (VBN determined)
            (PP (IN by)
              (NP
                (NP (JJ liquid) (NN scintillation) (NN spectroscopy))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Packard) (NNP Topcount))
                    (, ,)
                    (NP (NNP Packard) (NN Instrument) (NNP Co))
                    (, ,)
                    (NP (NNP Meriden))
                    (, ,)
                    (NP (NN CT))
                    (, ,)
                    (NP (NNP USA)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN IFN-γ))
        (, ,)
        (NP (NN IL-10))
        (, ,)
        (CC and)
        (NP (NN TNF-α)))
      (VP (VBD were)
        (VP (VBN measured)
          (PP (IN in)
            (NP (NNS supernatants)))
          (PP (IN by)
            (NP
              (NP (NN ELISA))
              (VP (VBG using)
                (NP
                  (NP (NN OptEIA) (NN ELISA) (NNS kits))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP BD) (NNP Pharmingen))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (ADJP
            (ADJP (JJ Frozen))
            (CC or)
            (ADJP (JJ paraffin-embedded)))
          (NNS sections))
        (PP (IN of)
          (NP
            (NP (JJ synovial) (NN tissue))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (JJ untreated) (JJ active) (NN RA))))))))
      (VP (VBD were)
        (VP
          (VP (VBN obtained)
            (PP (IN by)
              (NP (JJ arthroscopic) (NN biopsy))))
          (CC and)
          (VP (VBN supplied)
            (PP (IN by)
              (NP
                (NP (NNP Malcolm) (NNP Smith))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Repatriation) (NNP Hospital))
                    (, ,)
                    (NP (NN Adelaide))
                    (, ,)
                    (NP (NNP Australia)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Normal) (JJ synovial) (NN tissue))
      (VP (VBD was)
        (VP (VBN obtained)
          (PP (IN at)
            (NP (NN arthroscopy)))
          (PP (IN from)
            (NP
              (NP (NNS patients))
              (VP (VBG undergoing)
                (NP (NN arthroscopy))
                (PP (IN for)
                  (NP
                    (NP (JJ nonspecific) (NN knee) (NN pain))
                    (SBAR (CC and)
                      (WHPP (IN in)
                        (WHNP (WP whom)))
                      (S
                        (NP (DT no) (NN abnormality))
                        (VP (VBD was)
                          (VP (VBN found)))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN fixation))
          (PP (IN with)
            (NP (NN acetone)))))
      (, ,)
      (NP (NNS sections))
      (VP (VBD were)
        (VP
          (VP (VBN stained)
            (PP (IN with)
              (NP
                (NP (NN anti-CD11c))
                (CC or)
                (NP (NN anti-CD123))))
            (S
              (VP (VBG using)
                (NP (DT an) (NN immunoperoxidase) (NN technique)))))
          (, ,)
          (CC and)
          (VP (VBN revealed)
            (PP (IN with)
              (NP
                (NP (NN diaminobenzidine))
                (PRN (-LRB- -LRB-)
                  (NP (NN brown))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Frozen) (NNS sections))
      (VP (VBD were)
        (VP (VBN double-stained)
          (PP (IN with)
            (NP
              (NP
                (NP (NNP U.) (FW europaeus) (NN agglutinin) (CD I))
                (PRN (-LRB- -LRB-)
                  (NP (NN Ulex))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (DT a) (NN lectin))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (ADVP (RB specifically))
                    (VP (VBZ binds)
                      (NP
                        (NP (JJ endothelial) (NNS cells))
                        (PRN (-LRB- -LRB-)
                          (NP (JJ fast) (JJ red))
                          (-RRB- -RRB-)))))))
              (, ,)
              (CC and)
              (NP
                (NP (NN anti-CD123))
                (PRN (-LRB- -LRB-)
                  (NP (NN brown))
                  (-RRB- -RRB-)))))
          (, ,)
          (S
            (VP (VBG using)
              (NP (DT a) (JJ double) (, ,) (JJ immunoperoxidase–immunoalkaline) (NN phosphatase) (NN technique))
              (PP (IN as)
                (NP (VBN described) (NN elsewhere) (CD -LSB-34) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP
          (ADJP (JJ Formalin-fixed))
          (ADJP (JJ paraffin-embedded)))
        (NNS sections))
      (VP (VBD were)
        (ADJP (JJ antigen-retrieved)
          (PP (IN in)
            (NP
              (NP
                (ADJP (CD 10) (NN mM))
                (NN citrate) (NN buffer))
              (PP (IN at)
                (NP (NN pH6))))))
        (PP (IN in)
          (NP (DT an) (JJ autoclave)))
        (, ,)
        (ADVP (RB then))
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP
                (NP (NN anti-CD123))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN diaminobenzidine))
                    (, ,)
                    (NP (NN brown)))
                  (-RRB- -RRB-)))
              (UCP
                (ADVP (RB alone))
                (, ,)
                (CC or)
                (PP (IN in)
                  (NP
                    (NP (NN combination))
                    (PP (IN with)
                      (NP
                        (NP (NN anti-RelB))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN BCIP))
                            (, ,)
                            (NP (NN DAKO))
                            (, ,)
                            (NP (NN purple)))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Sections))
      (VP
        (VP (VBD were)
          (ADJP (JJ counterstained)
            (PP (IN with)
              (NP (NN hematoxylin))))
          (PP (IN except)
            (SBAR
              (WHADVP (WRB when))
              (S
                (NP (PRP they))
                (VP (VBD had)
                  (VP (VBN been)
                    (VP (VBN double-stained)
                      (PP (IN for)
                        (NP
                          (NP (NN CD123))
                          (CC and)
                          (NP (NN RelB)))))))))))
        (CC and)
        (VP (VBD were)
          (VP (VBN photographed)
            (S
              (VP (VBG using)
                (NP
                  (NP (DT a) (JJ transmitted-light) (NN microscope))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Leitz) (NNP Diaplan))
                      (, ,)
                      (NP (NNP Leica) (, ,) (NNP Germany)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB quantitate)
            (NP
              (NP (NN infiltration))
              (PP (IN by)
                (NP (JJ CD123+) (NNS DCs)))))))
      (, ,)
      (NP
        (NP (DT the) (NN number))
        (PP (IN of)
          (NP (NN CD123+Ulex-) (NNS cells))))
      (VP (VBD was)
        (VP (VBN counted)
          (PP (IN in)
            (NP
              (NP (NNS sections))
              (VP (VBN double-stained)
                (PP (IN with)
                  (NP
                    (NP (NN CD123))
                    (CC and)
                    (NP (NN Ulex))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Cells))
        (VP (VBD were)
          (VP (VBN counted)
            (PP (IN in)
              (NP
                (NP (DT each))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ entire) (NNS sections))
                    (PP (IN from)
                      (NP
                        (NP
                          (NP (CD three) (NNS patients))
                          (CC and)
                          (NP (CD three) (JJ normal) (NNS controls)))
                        (PP (IN at)
                          (NP (JJ high) (NN power))))))))))))
      (, ,)
      (CC and)
      (S
        (PP (IN for)
          (NP (DT each) (NN biopsy)))
        (NP (DT this) (NN number))
        (VP (VBD was)
          (VP (VBN corrected)
            (PP (IN for)
              (NP
                (NP (DT the) (NN area))
                (PP (IN of)
                  (NP (DT the) (NN section)
                    (S
                      (VP (TO to)
                        (VP (VB obtain)
                          (NP
                            (NP (DT the) (NN number))
                            (PP (IN per)
                              (NP (NNS mm2)))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB quantitate)
            (NP
              (NP (NN infiltration))
              (PP (IN by)
                (NP (NN CD11c+) (NNS cells)))))))
      (, ,)
      (NP
        (NP (DT the) (NN number))
        (PP (IN of)
          (NP (DT these) (NNS cells))))
      (VP (VBD was)
        (VP (VBN counted)
          (PP (IN in)
            (NP
              (NP (CD three) (JJ high-power) (NNS fields))
              (PP (IN of)
                (NP
                  (NP (DT the) (JJ synovial) (NN sublining))
                  (PP (IN in)
                    (NP
                      (NP (NNS sections))
                      (PP (IN from)
                        (NP
                          (NP (CD three) (NNS patients))
                          (CC and)
                          (NP (CD three) (JJ normal) (NNS controls)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Differences))
      (VP (VBD were)
        (VP (VBN analyzed)
          (S
            (VP (VBG using)
              (NP (JJ unpaired) (NN Student) (POS 's) (NNS t-tests)))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP
                (NP (JJ synovial) (NN tissue))
                (PP (IN in)
                  (NP
                    (NP (NN RA))
                    (CC and)
                    (NP (NN spondyloarthropathy)))))
              (VP (VBZ is)
                (VP (VBN enriched)
                  (PP (IN in)
                    (NP
                      (NP (VBN differentiated) (JJ myeloid) (NNS DCs))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (VBP express)
                            (NP
                              (NP (NN CD33))
                              (, ,)
                              (NP (NN CD11c))
                              (, ,)
                              (NP (NN MHC) (NN class) (CD II))
                              (, ,)
                              (NP (JJ costimulatory) (NNS molecules))
                              (, ,)
                              (CC and)
                              (NP (JJ nuclear) (NN RelB) (NN -LSB-21,25))))
                          (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Translocation))
        (PP (IN of)
          (NP (NN RelB)))
        (PP (TO to)
          (NP (DT the) (NN nucleus))))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (NN maturation))
                (CC and)
                (NP (NN APC) (NN function)))
              (PP (IN of)
                (NP (JJ myeloid) (NNS DCs) (CD -LSB-26) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (JJ nuclear) (NN RelB+) (NNS DCs))
      (VP
        (VP (VBP are)
          (ADJP (JJ absent)
            (PP (IN in)
              (NP (JJ normal) (JJ synovial) (NN tissue)))))
        (CC and)
        (VP (VBP are)
          (ADJP (JJ rare)
            (PP (IN in)
              (NP (NN RA) (NN SF) (CD -LSB-21,23))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB determine)
          (SBAR (IN whether)
            (S
              (NP
                (ADJP (NN RA) (JJ synovial))
                (NN tissue))
              (VP (VBD was)
                (VP (VBN infiltrated)
                  (PP
                    (PP (IN by)
                      (NP
                        (NP (JJ CD123+) (NNS pDCs))
                        (PP (IN in) (NN addition) (TO to)
                          (NP
                            (NP (JJ CD11c+) (JJ myeloid) (NNS cells))
                            (, ,)
                            (NP (NN frozen) (JJ synovial) (NN tissue) (NNS sections))
                            (, ,)
                            (CC either)
                            (NP
                              (ADJP (JJ normal)))))))
                    (CC or)
                    (PP (IN from)
                      (NP
                        (NP (NNS patients))
                        (PP (IN with)
                          (NP
                            (NP (NN RA))
                            (CC or)
                            (NP (NN spondyloarthropathy))))))))))))))
    (, ,)
    (VP (VBD were)
      (VP (VBN stained)
        (PP (IN with)
          (NP
            (NP (NN CD11c))
            (CC or)
            (NP (NN CD123))))))
    (. .)))

(
  (S
    (S
      (NP (NN CD11c+) (NNS cells))
      (VP (VBD were)
        (VP (VBN found)
          (UCP (CC both)
            (PP (IN in)
              (NP (DT the) (JJ lining) (NN layer)))
            (CC and)
            (ADJP (JJ adjacent)
              (PP (TO to)
                (NP
                  (NP (NNS vessels))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN sublining))
                      (PP (IN of)
                        (NP (JJ normal) (JJ synovial) (NN tissue))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (NN CD123))
      (ADVP (RB only))
      (VP (VBN stained)
        (NP
          (NP (JJ endothelial) (NNS cells))
          (PP (IN in)
            (NP (DT the) (JJ normal) (NN tissue))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNP Fig.))
            (NP (NN 1a,1b)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN RA) (JJ synovial) (NN tissue)))
      (, ,)
      (NP (NN CD11c))
      (ADVP (RB again))
      (VP (VBN stained)
        (NP
          (NP (NNS cells))
          (ADJP (JJ adjacent)
            (PP
              (PP (TO to)
                (NP (NNS vessels)))
              (, ,)
              (ADVP (RB now))
              (PP (IN within)
                (NP
                  (NP (JJ lymphoid) (NNS aggregates))
                  (PP (IN in)
                    (NP (DT the) (NN sublining))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN population))
        (PP (IN of)
          (NP
            (NP (JJ CD123+) (NNS cells))
            (PP (IN with)
              (NP (JJ dendritic) (NN appearance))))))
      (VP (VBD was)
        (ADVP (RB also))
        (VP (VBN stained)
          (S
            (ADJP (JJ adjacent)
              (PP (TO to)
                (NP
                  (NP (JJ CD123+) (NN blood) (NNS vessels))
                  (PP (IN in)
                    (NP
                      (NP (NN RA))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (NNP Fig.) (NNP 1c,1d))
                          (, ,))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Cells))
        (VP (VBG expressing)
          (NP
            (NP (NN TNF-α))
            (PP (IN in)
              (NP (NN RA) (JJ synovial) (NN tissue))))))
      (VP (VBD were)
        (VP (VBN found)
          (PP (IN in)
            (NP
              (NP (DT a) (JJ similar) (NN location))
              (PP (IN in)
                (NP
                  (NP (JJ serial) (NNS sections))
                  (PRN (-LRB- -LRB-)
                    (S
                      (NP (NNS data))
                      (VP (RB not) (VBN shown)))
                    (-RRB- -RRB-)))))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN demonstrated)
              (ADVP (RB previously))
              (NP (CD -LSB-35) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB confirm)
          (NP
            (NP (DT the) (JJ perivascular) (JJ CD123+) (NNS cells))
            (PP (IN in)
              (NP (JJ synovial) (NN tissue)))))))
    (, ,)
    (NP
      (NP
        (ADJP (JJ normal)))
      (CC and)
      (NP
        (ADJP (NN RA) (JJ synovial))
        (NN tissue)))
    (VP (VBD were)
      (VP (VBN double-stained)
        (PP
          (PP (IN with)
            (NP
              (NP (DT the) (JJ endothelial) (NN cell) (NN marker) (NN Ulex) (NN agglutinin))
              (PRN (-LRB- -LRB-)
                (NP (JJ red))
                (-RRB- -RRB-))))
          (CC and)
          (PP (IN with)
            (NP
              (NP (NN CD123))
              (PRN (-LRB- -LRB-)
                (NP (NN brown))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whereas)
        (S
          (NP
            (NP (DT all) (JJ CD123+) (NNS structures))
            (PP (IN in)
              (NP (JJ normal) (JJ synovial) (NN tissue))))
          (VP (VBD colocalized)
            (PP (IN with)
              (NP
                (NP (NN Ulex) (NN agglutinin))
                (PRN (-LRB- -LRB-)
                  (NP (NN orange))
                  (-RRB- -RRB-)))))))
      (, ,)
      (NP
        (NP (JJ single-stained) (JJ CD123+) (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP (NN brown))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (ADJP
          (ADJP (JJ located)
            (PP (IN in)
              (NP (JJ perivascular) (JJ lymphoid) (NNS aggregates))))
          (CC and)
          (PP (IN within)
            (NP
              (NP (DT the) (NN lumen))
              (PP (IN of)
                (NP
                  (NP (JJ occasional) (NN blood) (NNS vessels))
                  (PP (IN in)
                    (NP
                      (NP
                        (ADJP (NN RA) (JJ synovial))
                        (NN tissue))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Fig.) (NNP 1e,1f))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (JJ CD123+) (NNS cells))
      (VP (VBP are)
        (ADJP (JJ similar)
          (PP (IN in)
            (NP (NN appearance)))
          (PP (TO to)
            (NP
              (NP (DT those))
              (VP
                (ADVP (RB previously))
                (VBN demonstrated)
                (PP (IN as)
                  (NP
                    (NP (JJ CD123+) (NNS pDCs))
                    (PP (IN in)
                      (NP (JJ human) (NN tonsil)))
                    (, ,)
                    (SBAR
                      (SBAR
                        (WHPP (IN in)
                          (WHNP (WDT that)))
                        (S
                          (NP (PRP they))
                          (VP (VBP are)
                            (ADJP (JJR smaller)
                              (PP (IN than)
                                (NP (JJ CD11c+) (JJ myeloid) (NNS DCs)))
                              (, ,)
                              (PP (IN with)
                                (NP (JJR shorter) (JJ dendritic) (NNS processes)))))))
                      (, ,)
                      (CC and)
                      (S
                        (NP (NN cell) (NNS clusters))
                        (VP (VBD gave)
                          (NP
                            (NP (DT the) (NN appearance))
                            (PP (IN of)
                              (NP
                                (NP
                                  (ADJP (RB locally) (VBG proliferating))
                                  (NNS cells))
                                (PRN (-LRB- -LRB-)
                                  (NP (NNP Fig.) (NN 1g) (-RRB- -RRB-) (CD -LSB-5,36))
                                  (-RRB- -RSB-))))))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN While)
        (S
          (NP (DT some) (NNS macrophages))
          (VP (MD can)
            (VP (VB express)
              (NP (NN CD123))))))
      (, ,)
      (NP (EX there))
      (VP (VBD was)
        (NP
          (NP (DT no) (NN colocalization))
          (PP (IN in)
            (NP (JJ synovial) (NN tissue)))
          (PP (IN of)
            (NP
              (NP (NN CD123))
              (CC and)
              (NP (NN CD68)))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (PP (IN aside) (IN from)
        (NP (DT the) (JJ dendritic) (NN morphology)))
      (, ,)
      (NP (PRP we))
      (ADVP (RB cannot))
      (VP (VBP exclude)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT some))
              (PP (IN of)
                (NP
                  (NP (DT the) (JJ CD123+) (NNS cells))
                  (VP (VBN stained)))))
            (VP (VBP are)
              (NP (NN mast) (NNS cells) (CD -LSB-37) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB determine)
            (SBAR (IN whether)
              (S
                (NP
                  (NP (NN CD123+) (NNS cells))
                  (PP (IN in)
                    (NP (JJ synovial) (NN tissue))))
                (VP (VBD were)
                  (ADVP (RB also))
                  (NP (JJ nuclear) (NN RelB+))))))))
      (, ,)
      (NP (JJ formalin-fixed) (NN tissue))
      (VP (VBD was)
        (ADJP (JJ double-stained)
          (PP (IN for)
            (NP
              (NP (NN RelB))
              (CC and)
              (NP (NN CD123)))))
        (PP (IN without)
          (NP (NN hematoxylin) (NN counterstaining)))))
    (. .)))

(
  (S
    (S
      (NP (DT No) (JJ CD123+) (NNS cells))
      (VP (VBD had)
        (VP (VBD translocated)
          (NP (NN RelB))
          (PP (TO to)
            (NP (DT the) (NN nucleus)))
          (, ,)
          (SBAR (IN although)
            (S
              (NP (DT some))
              (VP (VBD expressed)
                (NP
                  (NP (JJ cytoplasmic) (NN RelB))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (NNP 1h,1i))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (JJ nuclear) (NN staining))
      (PP (IN of)
        (NP (NN RelB))))
    (VP (VBD was)
      (ADJP (JJ evident))
      (PP (IN in)
        (NP
          (NP (JJ adjacent) (NN CD123-) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Fig.))
              (NP (NN 1h)))
            (, ,)
            (NP (NNS arrows))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT All) (NNS patients))
          (PP (IN with)
            (NP (NN RA))))
        (VP (VBD showed)
          (NP
            (NP (JJ similar) (NN infiltration))
            (PP (IN by)
              (NP (NN pDCs))))))
      (CC and)
      (S
        (NP
          (NP (DT no) (NNS differences))
          (PP (IN in)
            (NP
              (NP (DT the) (NN cell) (NNS numbers))
              (CC or)
              (NP (NN location)))))
        (VP (VBD were)
          (VP (VBN noted)
            (PP (IN between)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP
                    (NP (NN RA))
                    (CC or)
                    (NP (NN spondyloarthropathy))))))
            (PRN (-LRB- -LRB-)
              (S
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBN quantitated)
        (NP
          (NP (NNS pDCs))
          (PP (IN in)
            (NP
              (ADJP
                (ADJP (JJ normal))
                (CC or)
                (ADJP (NN RA) (JJ synovial)))
              (NN tissue))))
        (PP (IN by)
          (S
            (VP (VBG counting)
              (NP (NN CD123+Ulex-) (NNS cells))
              (PP (IN in)
                (NP
                  (NP (JJ synovial) (NN tissue) (NNS sections))
                  (PP (IN from)
                    (NP
                      (NP
                        (NP (NNS patients))
                        (PP (IN with)
                          (NP (NN RA))))
                      (CC or)
                      (NP (JJ normal) (NNS controls))))
                  (VP (VBN stained)
                    (PP (IN with)
                      (NP
                        (NP
                          (NP (NN CD123))
                          (CC and)
                          (NP (NN Ulex)))
                        (SBAR (IN as)
                          (S
                            (VP (VBN shown)
                              (PP (IN in)
                                (NP (NNP Fig.) (CD 1))))))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whereas)
        (S
          (NP (DT no) (NNS pDCs))
          (VP (VBD infiltrated)
            (NP (DT the) (JJ normal) (NN tissue)))))
      (, ,)
      (NP
        (NP
          (QP (RB approximately) (CD 22))
          (NNS pDCs))
        (PP (IN per)
          (NP (NNS mm2))))
      (VP (VBD were)
        (VP (VBN identified)
          (PP (IN within)
            (NP (DT the) (NN RA) (NN tissue)))
          (PRN (-LRB- -LRB-)
            (NP (NNP Fig.) (CD 2))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN number))
      (VP (VBZ is)
        (ADJP (JJ similar)
          (PP (TO to)
            (NP
              (NP (DT the) (NN number))
              (PP (IN of)
                (NP (JJ nuclear) (JJ RelB+) (VBN differentiated) (NNS DCs)))
              (VP (VBN identified)
                (ADVP (RB previously))
                (PP (IN in)
                  (NP
                    (ADJP (NN RA) (JJ synovial))
                    (NN tissue) (CD -LSB-38) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (NN CD11c+) (NNS cells))
      (VP (VBD infiltrated)
        (NP
          (ADJP (CC both)
            (ADJP (JJ normal))
            (CC and)
            (ADJP (NN RA) (JJ synovial)))
          (NN tissue))
        (, ,)
        (PP (IN with)
          (NP
            (NP
              (ADJP (RB significantly) (JJR larger))
              (NNS numbers))
            (PP (IN in)
              (NP
                (NP
                  (NP (NN RA))
                  (PRN (-LRB- -LRB-)
                    (NP (NN P) (NN <) (CD 0.05))
                    (-RRB- -RRB-)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 2))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP conclude)
        (SBAR
          (SBAR (IN that)
            (S
              (NP (DT the) (JJ CD123+) (NN cell) (NN population))
              (VP (VBZ is)
                (ADVP (RBS most) (RB likely))
                (NP
                  (NP
                    (NP (DT a) (JJ pDC) (NN population))
                    (PP (IN that)
                      (NP (NNS infiltrates)
                        (NP
                          (NP (NN RA))
                          (CC and)
                          (NP (NN spondyloarthropathy))))))
                  (CONJP (CC but)
                    (RB not))
                  (NP (JJ normal) (JJ synovial) (NN tissue))))))
          (CC and)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (VBZ is)
                (ADJP (JJ distinct)
                  (PP (IN from)
                    (NP (DT the) (VBN described) (JJ nuclear) (NN RelB+) (NN DCs) (CD -LSB-21,36,39) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN CD11c+) (NNS cells))
      (VP (VBP comprise)
        (NP
          (ADJP
            (ADJP (JJ immature))
            (CC and)
            (ADJP (VBN differentiated)))
          (NP (JJ myeloid) (NNS DCs))
          (CONJP (RB as) (RB well) (IN as))
          (NP (NNS monocytes) (CD -LSB-1,34) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (VBN Differentiated) (JJ nuclear) (NN RelB+) (NNS DCs))
      (VP (VBP are)
        (VP (VBN found)
          (PP (IN within)
            (NP (DT the) (JJ CD11c+) (NN DC) (NN population)))
          (PP
            (PP (IN in)
              (NP
                (NP (NN RA))
                (CC and)
                (NP (JJ other) (JJ inflammatory) (NNS arthritides))))
            (CC but)
            (PP (RB not) (IN in)
              (NP (JJ normal) (JJ synovial) (NN tissue) (CD -LSB-21))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Workers))
        (PP (IN in)
          (NP (PRP$ our) (NN laboratory))))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (NN RA) (NN SF))
              (VP (VBZ is)
                (VP (VBN enriched)
                  (PP (IN in)
                    (NP
                      (NP (JJ CD11c+CD33brightCD14-) (JJ myeloid) (NNS DCs))
                      (PP (IN with)
                        (NP (JJ efficient) (NN APC) (NN function) (CD -LSB-25,40)))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (SBAR
        (WHADVP (WRB when))
        (S
          (ADVP (RB freshly))
          (VP (VBN isolated))))
      (, ,)
      (NP
        (NP (RB only) (DT a) (JJ small) (NN proportion))
        (PP (IN of)
          (NP (NN SF) (NN CD33brightCD14-) (NNS DCs))))
      (VP (VBP have)
        (VP (VBN translocated)
          (NP (NN RelB))
          (PP (TO to)
            (NP (DT the) (NN nucleus))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN RA))
          (CC and)
          (NP (JJ normal) (NN PB)))
        (JJ mononuclear) (NNS cells))
      (VP (VBP contain)
        (NP
          (NP (JJ similar) (NNS proportions))
          (PP (IN of)
            (NP (NN CD33brightCD14-) (NN DCs) (CD -LSB-25)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB examine)
          (NP
            (NP
              (NP (NN plasmacytoid))
              (CC and)
              (NP (JJ myeloid) (NNS DCs)))
            (PP (IN in)
              (NP (NN parallel)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD compared)
      (NP
        (NP (NN RA) (NN SF))
        (PP (IN with)
          (NP
            (NP (NN RA))
            (CC and)
            (NP
              (ADJP
                (ADJP (JJ healthy))
                (, ,)
                (ADJP (JJ control)))
              (NN PB))))
        (PP (IN for)
          (NP
            (NP (DT the) (NN proportion))
            (PP (IN of)
              (NP
                (NP (NN CD123+))
                (CC and)
                (NP (JJ CD11c+) (JJ HLA-DR+CD14-) (NNS DCs))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN purification))
          (PP (IN of)
            (NP
              (NP (JJ mononuclear) (NNS cells))
              (PP (IN from)
                (NP
                  (UCP (CC either)
                    (ADJP (JJ normal))
                    (CC or)
                    (NP (NN RA)
                      (NP (NN PB))
                      (CC or)
                      (NP (NN RA))))
                  (NN SF)))))
          (PP (IN by)
            (NP (NN gradient) (NN centrifugation)))))
      (, ,)
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NN CD123-PE))
              (, ,)
              (NP (NN CD11c-FITC))
              (, ,)
              (NP (NN CD14-PECy5))
              (, ,)
              (CC and)
              (NP (NN HLA-DR-APC)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Polymorphonuclear) (NNS cells))
      (VP (VBD were)
        (VP (VBN excluded)
          (PP (IN on)
            (NP
              (NP (DT the) (NN basis))
              (PP (IN of)
                (NP
                  (ADJP
                    (ADJP (JJ forward))
                    (CC and)
                    (ADJP (JJ side)))
                  (NN light-scatter))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP
            (NP (NNS basophils))
            (CC and)
            (NP (NNS monocytes)))
          (VP (MD can)
            (ADVP (RB also))
            (VP (VB express)
              (NP (NN CD123))))))
      (, ,)
      (NP (JJ potential) (JJ CD123+) (NNS non-DCs))
      (VP (VBD were)
        (VP (VBN excluded)
          (PP (IN by)
            (S
              (VP (VBG gating)
                (NP (JJ CD14-HLA-DR+) (NNS cells) (CD -LSB-10) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN By)
        (NP (NN four-color) (NN analysis)))
      (, ,)
      (NP
        (ADJP
          (ADJP (JJ CD14-HLA-DR+CD123+))
          (CC and)
          (ADJP (JJ CD11c+)))
        (NN DC) (NNS populations))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN distinguished)
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 3))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS percentages))
        (PP (IN of)
          (NP (JJ CD123+CD11c-) (NNS pDCs)))
        (PP (IN in)
          (NP
            (NP (NN RA) (NN PB))
            (CC and)
            (NP (JJ normal) (NN PB)))))
      (VP
        (VP (VBD were)
          (ADJP (JJ low)))
        (CC and)
        (VP (VBD did) (RB not)
          (VP (VB differ)
            (PP (IN from)
              (NP (DT each) (JJ other)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN observation))
      (VP (VBZ contrasts)
        (PP (IN with)
          (NP
            (NP (DT the) (NN reduction))
            (PP (IN in)
              (NP (NNS pDCs)))
            (VP (VBN observed)
              (PP (IN in)
                (NP
                  (NP (NN blood))
                  (PP (IN from)
                    (NP
                      (NP (NNS patients))
                      (PP (IN with)
                        (NP (JJ systemic) (NN lupus) (NN erythematosus) (CD -LSB-41) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CD11c+CD123-) (JJ myeloid) (NNS DCs))
      (VP (VBD were)
        (ADJP (RBR more) (JJ common))
        (PP (IN than)
          (NP (JJ CD123+) (NNS DCs)))
        (PP (IN in)
          (NP
            (NP (NN patient))
            (CC and)
            (NP (NN control))
            (NP (NN blood))))
        (PRN (-LRB- -LRB-)
          (NP (NN P) (JJ <) (CD 0.005))
          (-RRB- -RRB-))
        (, ,)
        (PP (IN in)
          (S
            (VP (VBG keeping)
              (PP (IN with)
                (NP
                  (NP (JJ previous) (NNS studies))
                  (PP (IN of)
                    (NP (JJ normal) (NN PB) (NN -LSB-1))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (NP (NN RA) (NN SF))
    (VP (VBD contained)
      (NP
        (NP (DT a)
          (ADJP (RB significantly) (JJR greater))
          (NN percentage))
        (PP (IN of)
          (NP (JJ CD11c+) (NNS DCs))))
      (PP (IN than)
        (NP
          (NP
            (NP
              (ADJP (JJ normal)))
            (CC or)
            (NP
              (NP (NN RA) (NN PB))
              (PRN (-LRB- -LRB-)
                (NP (NN P) (JJ <) (CD 0.005))
                (-RRB- -RRB-)))
            (NP (NNS –)))
          (SBAR (IN in)
            (S
              (VP (VBP accord)
                (PP (IN with)
                  (NP
                    (NP (JJ previous) (NNS studies))
                    (VP (VBG using)
                      (NP (DT the) (NNS markers)
                        (NP
                          (NP (NN CD33))
                          (CC and)
                          (NP (NN CD14) (NN -LSB-40)))
                        (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN proportion))
        (PP (IN of)
          (NP (JJ CD11c+) (NNS DCs)))
        (PP (IN in)
          (NP (NN RA) (NN SF))))
      (VP (VBD was)
        (ADJP
          (ADJP (JJR higher))
          (PP (IN than)
            (NP
              (NP (DT that))
              (PP (IN of)
                (NP
                  (NP (NN RA) (NN SF) (NN CD123+) (NNS DCs))
                  (PRN (-LRB- -LRB-)
                    (NP (NN P) (NN <) (CD 0.05))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP (DT the) (NN difference))
          (VP (VBD was)
            (ADJP (JJ small)))))
      (, ,)
      (NP
        (NP (DT the) (NN percentage))
        (PP (IN of)
          (NP
            (NP (JJ CD123+) (NNS DCs))
            (PP (IN in)
              (NP (NN RA) (NN SF))))))
      (VP (VBD was)
        (ADJP
          (ADJP (JJR higher))
          (PP (IN than)
            (PP (IN in)
              (NP
                (NP (NN RA))
                (CC or)
                (NP
                  (NP (JJ control) (NN PB))
                  (PRN (-LRB- -LRB-)
                    (NP (NN P) (NN <) (CD 0.05))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS data))
      (VP (VBP show)
        (SBAR
          (SBAR (IN that)
            (S
              (NP (JJ CD123+) (NNS DCs))
              (VP (VBP are)
                (ADJP (JJ present)
                  (PP (IN in)
                    (NP (NN RA) (NN SF)))))))
          (, ,)
          (CC and)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN ratio))
                (PP (IN of)
                  (NP (JJ CD11c+) (TO to) (JJ CD123+) (NNS DCs))))
              (VP (VBZ is)
                (ADJP (JJ similar)
                  (PP (IN in)
                    (NP (NN RA) (NN SF)))
                  (PP (TO to)
                    (NP
                      (NP (DT that))
                      (PP (IN in)
                        (NP
                          (NP
                            (ADJP (JJ normal)))
                          (CC or)
                          (NP (NN RA))
                          (NP (NN PB)))))))
                (PRN (-LRB- -LRB-) (RB approximately)
                  (VP (VBN 10:1))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN RA) (JJ synovial) (NN tissue)))
      (, ,)
      (NP (JJ mature) (JJ myeloid) (JJ nuclear)
        (ADJP
          (ADJP (JJ RelB+))
          (CC and)
          (ADJP (JJ CD123+)))
        (NNS DCs))
      (VP (VBP have)
        (VP (VBN infiltrated)
          (NP
            (NP (JJ perivascular) (JJ lymphoid) (NNS aggregates))
            (PP (IN in)
              (NP (JJ similar) (NNS numbers)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Previously))
      (, ,)
      (NP
        (NP (JJ similar) (NNS numbers))
        (PP (IN of)
          (NP
            (ADJP
              (ADJP (JJ immature))
              (CC and)
              (ADJP (JJ mature)))
            (JJ myeloid) (NNS DCs))))
      (VP (VBD were)
        (VP (VBN identified)
          (PP (IN in)
            (NP (NN RA) (JJ synovial) (NN tissue) (CD -LSB-42)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP (NNS pDCs))
      (VP (VBP make)
        (PRT (RP up))
        (NP
          (NP
            (QP (RB about) (CD 30))
            (NN %))
          (PP (IN of)
            (NP
              (NP (NNS DCs))
              (PP (IN within)
                (NP (NN RA) (JJ synovial) (NN tissue))))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (JJ present)
        (ADJP (CC and)
          (RB previously) (VBN published))
        (NNS data))
      (, ,)
      (VP (VBN taken)
        (ADVP (RB together)))
      (, ,))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (CC both)
            (NP (NNS pDCs))
            (CC and)
            (NP (JJ myeloid) (NNS DCs)))
          (VP (VBP are)
            (VP (VBN recruited)
              (PP (TO to)
                (NP (NN RA) (NN synovium)))
              (, ,)
              (PP (IN with)
                (NP
                  (NP (DT an) (NN enrichment))
                  (PP (IN of)
                    (NP (NN pDCs)))
                  (PP (IN in)
                    (NP
                      (NP (JJ synovial) (NN tissue))
                      (ADJP (JJ relative)
                        (PP (TO to)
                          (NP
                            (NP (NN blood))
                            (CC or)
                            (NP (NN SF))))))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (JJ normal) (NN PB)))
    (, ,)
    (NP (NNS pDCs))
    (VP (VBP circulate)
      (PP (IN as)
        (NP
          (NP (NNS precursors))
          (PP (IN with)
            (NP
              (NP (DT the) (NN potential))
              (PP (IN for)
                (NP
                  (NP (NN recruitment))
                  (PP (IN into)
                    (NP
                      (NP (NNS tissues))
                      (PP (IN in)
                        (NP
                          (NP (NN response))
                          (PP (TO to)
                            (NP (NNS chemokines) (CD -LSB-2,43))))))))))))))
    (-RRB- -RSB-) (. .)))

(
  (S
    (S
      (NP (DT These) (NNS precursors))
      (VP (VBP exhibit)
        (NP (DT a) (JJ characteristic) (NN plasmacytoid) (NN morphology))
        (PP (IN on)
          (NP (NN electron) (NN microscopy)))
        (, ,)
        (NP
          (NP (DT a) (JJ cell-surface) (NN phenotype))
          (VP (VBN characterized)
            (PP
              (PP (IN by)
                (NP
                  (NP (NN expression))
                  (PP (IN of)
                    (NP (DT the) (NN BDCA2) (NN antigen)))))
              (, ,)
              (PP (IN by)
                (NP
                  (NP (JJ low) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (JJ costimulatory) (NN molecule))
                      (NN expression)))))
              (, ,)
              (CC and)
              (PP (IN by)
                (NP
                  (NP (DT the) (NN potential))
                  (PP (IN for)
                    (NP (NN IFN-α) (NN production)))))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP
                      (NP
                        (ADJP (JJ viral)))
                      (CC or)
                      (NP (NN immunostimulatory) (NN CpG) (NN DNA) (NNS motifs))
                      (NP (NN -LSB-1))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP
        (VP (VBD analyzed)
          (NP
            (NP (DT the) (NNS characteristics))
            (PP (IN of)
              (NP (VBN sorted) (NN RA) (NN SF) (JJ CD123+) (NNS DCs)))))
        (CC and)
        (VP (VBD compared)
          (NP (PRP them))
          (PP (IN with)
            (NP (NN control) (NN PB) (JJ CD123+) (NNS DCs))))))
    (. .)))

(
  (S
    (PP (IN On)
      (NP (NN electron) (JJ microscopic) (NN examination)))
    (, ,)
    (NP
      (NP
        (ADJP (RB freshly) (VBN sorted))
        (NN PB))
      (CC and)
      (NP (NN SF) (NN CD123+) (NNS DCs)))
    (VP (VBD appeared)
      (ADJP (JJ similar))
      (, ,)
      (PP (IN with)
        (NP
          (NP (DT a) (NN smooth) (NN surface)
            (CC and)
            (JJ abundant) (JJ rough) (JJ endoplasmic) (NN reticulum))
          (PP (IN in)
            (NP (DT the) (NN cytoplasm))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN nucleus))
      (VP
        (VP (VBD was)
          (ADJP
            (ADJP (JJ nonlobulated))
            (CC and)
            (ADJP (JJ abundant)))
          (PP (IN in)
            (NP (NN euchromatin))))
        (CC and)
        (VP (VBD contained)
          (NP
            (NP (DT a) (JJ distinct) (NN nucleolus))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 4))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CD11c+) (NN PB) (NNS DCs))
      (VP (VBD were)
        (ADJP (RB morphologically) (JJ distinct)
          (PP (IN from)
            (NP (DT the) (JJ CD123+) (NNS pDCs))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (DT a) (VBN lobulated) (NN nucleus))
            (CC and)
            (NP (DT some) (JJ phagocytic) (NNS vesicles))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ CD11c+) (NNS DCs))
        (PP (IN from)
          (NP (NN SF))))
      (VP (VBD showed)
        (NP
          (NP (JJR more) (NN membrane) (NN ruffling))
          (CC and)
          (NP (JJ phagocytic) (NN activity)))
        (PP (IN than)
          (NP
            (NP (DT those))
            (PP (IN from)
              (NP
                (NP (NN PB))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 4))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP (NN SF) (NN CD123+) (NNS DCs))
      (ADVP (RB morphologically))
      (VP (VBP resemble)
        (NP
          (NP (JJ CD123+) (NNS DCs))
          (PP (IN in)
            (NP (NN PB))))))
    (, ,) (IN whereas)
    (S
      (NP (JJ CD11c+) (NN SF) (NNS DCs))
      (VP (VBP display)
        (NP
          (NP
            (NP (DT a) (JJR greater) (NN level))
            (PP (IN of)
              (NP (NN ruffling))))
          (CC and)
          (NP (JJ phagocytic) (NN activity)))
        (, ,)
        (S
          (ADJP (JJ consistent)
            (PP (IN with)
              (NP
                (NP (PRP$ their) (VBN enhanced) (NN level))
                (PP (IN of)
                  (NP (NN activation)))))))
        (, ,)
        (PP (IN than)
          (NP
            (NP (JJ CD11c+) (VBG circulating) (NNS precursors))
            (CD -LSB-21) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (PP (IN On)
        (NP (JJ four-color) (NN flow) (JJ cytometric) (NN analysis)))
      (, ,)
      (NP (JJ gated) (NN RA) (NN SF) (JJ CD14-HLA-DR+CD123+) (NNS DCs))
      (VP (VBD expressed)
        (NP
          (NP (JJ low) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NN CD40))
              (, ,)
              (NP (NN CD80))
              (, ,)
              (CC and)
              (NP (NN CD86)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (DT All))
          (CC or)
          (NP (DT the) (NN majority)))
        (PP (IN of)
          (NP (NN SF) (JJ CD123+) (NNS DCs))))
      (VP (VBD expressed)
        (NP
          (NP (DT the) (NN BDCA2) (NN marker))
          (PP (IN of)
            (NP
              (NP (JJ immature) (JJ pDC) (NNS precursors))
              (PRN (NN -LSB-1) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (NP (DT This) (JJ cell-surface) (NN phenotype))
    (ADVP (RB closely))
    (VP (VBZ resembles)
      (NP
        (NP (DT that))
        (PP (IN of)
          (NP (JJ control) (NN PB) (NN CD123+) (NN DC) (NNS precursors))))
      (, ,)
      (SBAR (IN although)
        (S
          (NP (NN BDCA2))
          (VP (VBD was)
            (ADVP (RB consistently))
            (VP (VBN expressed)
              (PP (IN at)
                (NP (JJ high) (NNS levels)))
              (PP
                (ADVP (RB only))
                (IN by)
                (NP
                  (NP (DT a) (NN subset))
                  (PP (IN of)
                    (NP
                      (NP (JJ CD123+) (JJ HLA-DR+) (NNS cells))
                      (PP (IN in)
                        (NP
                          (NP (NN PB))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Fig.) (CD 4b))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN No) (NN PB)
        (CC or)
        (NN SF) (NNS cells))
      (VP (VBD expressed)
        (NP (DT the) (NN DC) (NN differentiation) (NN marker) (NN CD83))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN SF) (NN CD123+)
        (CC and)
        (JJ CD11c+) (NNS DCs))
      (VP (VBD expressed)
        (NP
          (NP (JJR higher) (NNS levels))
          (PP (IN of)
            (NP (NN cell-surface) (NN HLA-DR))))
        (PP (IN than)
          (NP
            (NP (DT the) (JJ corresponding) (NNS cells))
            (PP (IN in)
              (NP (NN PB)))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (DT some) (JJ cellular) (NN activation))
              (PP (IN within)
                (NP (DT the) (NN SF) (NN environment) (CD -LSB-5,10,44)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP (JJ CD123+) (NNS pDCs))
      (VP (VBP comprise)
        (NP
          (NP (DT a) (JJ small) (NN proportion))
          (PP (IN of)
            (NP
              (NP (NN RA) (NN SF) (JJ mononuclear) (NNS cells))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP
                    (VP (VBP are)
                      (ADJP (RB predominantly) (JJ immature)))
                    (CC but)
                    (VP (VBP show)
                      (NP
                        (NP (DT some) (NN evidence))
                        (PP (IN of)
                          (NP (NN activation))))
                      (ADVP (FW in) (FW situ)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT These) (NNS observations))
        (PP (VBG regarding)
          (NP
            (NP
              (NP (NN phenotype))
              (CC and)
              (NP (NN PB)))
            (CC and)
            (NP (NN SF) (NNS numbers)))))
      (VP (VBP are)
        (ADJP (JJ consistent)
          (PP (IN with)
            (NP
              (NP (NNS findings))
              (PP (IN in)
                (NP
                  (NP (CD two) (JJ recent) (NNS studies))
                  (NP (CD -LSB-39,45) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP
                (ADJP (RB freshly) (VBN isolated))
                (JJ CD33brightCD14-CD11c+) (NN SF) (NNS DCs))
              (ADVP (RB efficiently))
              (VP (VBP stimulate)
                (NP (VBG resting) (NN T) (NNS cells))
                (PP (IN in)
                  (NP (JJ allogeneic) (JJ mixed) (NN lymphocyte) (NNS reactions)
                    (NP (CD -LSB-21))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP
            (ADJP (RB freshly) (VBN isolated))
            (JJ CD11c+) (NN PB) (NNS DCs))
          (VP (VBP are)
            (NP
              (NP (JJ efficient) (NNS APCs))
              (PP (IN in)
                (NP (JJ mixed) (NN lymphocyte) (NNS reactions)))))))
      (, ,)
      (NP (JJ CD123+) (NN PB) (NNS DCs))
      (ADVP (RB usually))
      (VP (VBP require)
        (NP
          (NP (JJ prior) (NN activation))
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP
                  (NP (NN IL-3))
                  (CC and)
                  (NP (NN CD154)))))))
        (PP (IN for)
          (NP
            (NP (NN acquisition))
            (PP (IN of)
              (NP (NN APC) (NN function)))
            (PP (IN in)
              (NP (DT this) (NN assay)))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB analyse)
            (NP
              (NP (DT the) (JJ functional) (NN capability))
              (PP (IN of)
                (NP (NN RA) (NN SF) (NNS DCs)))))))
      (, ,)
      (NP (JJ CD11c+)
        (CC and)
        (JJ CD123+) (NNS DCs))
      (VP (VBD were)
        (VP
          (VP (VBN sorted)
            (PP (IN from)
              (NP (CC either)
                (NP (JJ normal) (NN PB))
                (CC or)
                (NP (NN RA) (NN SF)))))
          (CC and)
          (VP (VBN incubated)
            (PP (IN with)
              (NP
                (ADJP (RB freshly) (VBN isolated))
                (JJ normal) (JJ allogeneic) (NN PB) (NN T) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP (RB Freshly) (VBN isolated))
        (ADJP
          (ADJP (NN PB) (JJ CD11c+))
          (CONJP (CC but)
            (RB not))
          (ADJP (JJ CD123+)))
        (NNS DCs))
      (ADVP (RB efficiently))
      (VP (VBD stimulated)
        (NP
          (NP (JJ allogeneic) (NN T-cell) (NN proliferation))
          (CC and)
          (NP (NN IFN-γ))
          (CC and)
          (NP (NN IL-10) (NN production)))
        (PP (IN in)
          (NP (JJ mixed) (NN lymphocyte) (NNS reactions)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Addition))
        (PP (IN of)
          (NP (NN IL-3))))
      (VP (VBD made)
        (NP (DT no) (NN difference))
        (PP (TO to)
          (NP (DT the) (NN T-cell) (NN proliferation)))
        (PP (IN in) (NN response) (TO to)
          (NP
            (NP (JJ CD123+) (NNS DCs))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (SBAR (IN that)
              (S
                (NP
                  (NP (NN death))
                  (PP (IN of)
                    (NP (DT the) (NNS APCs))))
                (VP (VBD was) (RB not)
                  (ADJP (JJ responsible)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (DT both)
        (ADJP (RB freshly) (VBN isolated))
        (ADJP
          (ADJP (JJ CD11c+))
          (CC and)
          (ADJP (JJ CD123+)))
        (NN SF) (NNS DCs))
      (ADVP (RB efficiently))
      (VP (VBD stimulated)
        (NP
          (NP
            (NP (NN proliferation))
            (CC and)
            (NP (NN IFN-γ)))
          (CC and)
          (NP (NN IL-10) (NN production)))
        (PP (IN by)
          (NP (VBG resting) (JJ normal) (JJ allogeneic) (NN T) (NNS cells)))
        (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 5))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ recent) (NN study))
      (VP (VBD demonstrated)
        (NP
          (NP (DT the) (NN capacity))
          (PP (IN of)
            (NP (NN RA) (NN SF)))
          (S
            (VP (TO to)
              (VP (VB inhibit)
                (NP (JJ pDC) (NN differentiation))
                (PP (IN in)
                  (NP (FW vitro) (NN -LSB-39) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ current) (NNS studies))
      (VP (VBP are)
        (ADJP (JJ consistent))
        (, ,)
        (PP (IN in)
          (SBAR (IN that)
            (S
              (S
                (NP (NN SF) (NNS pDCs))
                (VP (VBD showed)
                  (NP
                    (NP (RB only) (DT some) (NN evidence))
                    (PP (IN of)
                      (NP (NN activation))))
                  (ADVP (FW in) (FW situ))))
              (, ,)
              (CC but)
              (S
                (SBAR (IN once)
                  (S
                    (VP (VBN incubated)
                      (PP (IN in)
                        (NP
                          (NP (JJ mixed) (NN lymphocyte) (NNS reactions))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN absence))
                              (PP (IN of)
                                (NP (NN SF))))))))))
                (NP (PRP they))
                (VP (VBD displayed)
                  (NP
                    (NP (VBN enhanced) (NN APC) (NN function))
                    (ADJP (JJ relative)
                      (PP (TO to)
                        (NP
                          (NP (DT that))
                          (PP (IN of)
                            (NP (NN PB) (NNS pDCs))))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whereas)
        (S
          (NP
            (NP (NN stimulation))
            (PP (IN of)
              (NP (JJ mixed) (NN lymphocyte) (NNS reactions)))
            (PP (CC either)
              (PP (IN by)
                (NP (NN CD11c+)))
              (CC or)
              (PP (IN by)
                (NP (JJ CD123+) (NN PB) (NNS DCs)))))
          (VP (VBD resulted)
            (PP (IN in)
              (NP (JJ little) (NN TNF-α) (NN production))))))
      (, ,)
      (NP
        (NP (NN stimulation))
        (PP (IN by)
          (NP
            (NP (DT either))
            (PP (IN of)
              (NP
                (NP (DT these) (NNS DCs))
                (PP (IN from)
                  (NP (NN RA) (NN SF))))))))
      (VP (VBD resulted)
        (PP (IN in)
          (NP
            (NP (JJ high) (NNS levels))
            (PP (IN of)
              (NP
                (NP (JJ TNF-α) (NN secretion))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 5))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS data))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (NNS pDCs))
            (VP (VBP have)
              (NP
                (NP (DT the) (NN capacity))
                (PP (IN for)
                  (NP
                    (NP (VBN enhanced) (NN APC) (NN function))
                    (ADJP (JJ relative)
                      (PP (TO to)
                        (NP
                          (NP (NN PB) (NNS pDCs))
                          (VP
                            (ADVP (RB once))
                            (VBN removed)
                            (PP (IN from)
                              (NP (DT the) (NN RA) (NN SF) (NN environment)))))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (PP (IN at)
      (NP
        (NP (DT the) (NN time))
        (PP (IN of)
          (NP
            (NP (NN antigen) (NN presentation))
            (PP (IN by)
              (NP (NN SF) (NNS DCs)))
            (PP (TO to)
              (NP (NN T) (NNS cells)))))))
    (, ,)
    (S
      (NP
        (NP (NN production))
        (PP (IN of)
          (NP
            (NP (DT a) (NN number))
            (PP (IN of)
              (NP (NNS cytokines)))))
        (PP (IN by)
          (NP (CC either)
            (NP (NN T) (NNS cells))
            (CC or)
            (NP (NNS DCs)))))
      (VP (MD may)
        (VP (VB be)
          (VP (VBN stimulated) (, ,)
            (PP (VBG including)
              (NP (NN TNF-α)))))))
    (, ,)
    (CC and)
    (S
      (NP (DT this))
      (VP (VBZ appears)
        (S
          (VP (TO to)
            (VP (VB be)
              (NP
                (NP
                  (NP (DT a) (NN characteristic))
                  (PP (IN of)
                    (NP (NN RA) (JJ synovial) (NNS DCs))))
                (CONJP (RB rather) (IN than))
                (NP
                  (NP (DT the) (NN subtype))
                  (PP (IN of)
                    (NP (VBG stimulating) (NNS DCs))))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (NP
        (NP (JJ Ongoing) (NN inflammation))
        (PP (IN in)
          (NP (NN RA))))
      (VP (VBZ involves)
        (NP
          (NP (JJ positive) (NN feedback) (NNS loops))
          (PP (IN between)
            (NP
              (NP (VBN activated) (NN T) (NNS cells))
              (, ,)
              (NP (NN B) (NNS cells))
              (, ,)
              (NP (NNS DCs))
              (, ,)
              (NP (NNS macrophages))
              (, ,)
              (CC and)
              (NP (PRP$ their) (NNS products)))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (JJ destructive) (NNS consequences))
            (PP (IN for)
              (NP (JJ parenchymal) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP
          (ADJP (JJ Clinical))
          (CC and)
          (ADJP (JJ animal)))
        (NNS data))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (JJ effector-site) (NNS DCs))
            (VP
              (VP (VBP play)
                (NP (DT an) (JJ important) (JJ proinflammatory) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN perpetuation))
                    (PP (IN of)
                      (NP (JJ autoimmune) (NN disease))))))
              (CC and)
              (VP (VBP contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (JJ lymph-node-like) (NN organization))
                    (PP (IN of)
                      (NP (DT that) (NN tissue) (NN -LSB-22,46)))))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT This) (NN role))
        (VP (MD may)
          (VP (VB be)
            (VP (VBN effected)
              (PP (IN by)
                (NP
                  (NP (JJ local) (NN antigen) (NN presentation))
                  (PP (TO to)
                    (NP
                      (ADJP
                        (ADJP (JJ CD4+))
                        (CC and)
                        (ADJP (JJ CD8+)))
                      (NN effector) (NNS cells)))))))))
      (, ,)
      (CC but)
      (S
        (NP (NNS DC)
          (NP
            (NP (NN cytokine))
            (CC and)
            (NP (NN chemokine) (NN secretion))))
        (VP (VBP are)
          (ADVP (RB also))
          (ADJP (JJ important)
            (NP (CD -LSB-47,48) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN TNF-α))
        (CC and)
        (NP (NN IL-1β)))
      (VP (VBP are)
        (NP
          (ADJP
            (ADJP (JJ important))
            (ADJP (JJ downstream))
            (ADJP (JJ proinflammatory))
            (CC and)
            (ADJP (JJ destructive)))
          (NNS cytokines))
        (PP (IN in)
          (NP (NN RA)))
        (PP (IN for)
          (NP
            (NP (JJ somatic) (NNS cells))
            (, ,)
            (SBAR
              (WHNP (WP$ whose) (NN release))
              (S
                (VP (VBZ is)
                  (VP (VBN promoted)
                    (PP (IN by)
                      (NP
                        (NP (NN activation))
                        (PP (IN of)
                          (NP (NNS macrophages)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN IL-10))
        (VP (VBZ is)
          (ADVP (RB highly))
          (VP (VBN expressed)
            (PP (IN in)
              (NP (NN RA))))))
      (, ,)
      (CC and)
      (S
        (NP (NN IFN-γ))
        (VP (VBZ is)
          (NP (DT an) (JJ important) (NN T-cell) (NN effector) (NN cytokine) (CD -LSB-49,50) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT the) (JJ current) (NNS studies)))
    (, ,)
    (NP (PRP we))
    (VP (VBP show)
      (SBAR (IN that)
        (S (, ,)
          (PP (IN in) (NN addition) (TO to)
            (NP
              (NP (DT the)
                (ADJP (RB previously) (VBN described))
                (NN population))
              (PP (IN of)
                (NP (JJ nuclear) (JJ RelB+) (NNS DCs)))))
          (, ,)
          (NP
            (NP (DT a) (JJ further) (NN population))
            (PP (IN of)
              (NP (JJ nuclear) (JJ RelB-CD123+) (NNS pDCs))))
          (VP (VBZ is)
            (ADJP (JJ located)
              (PP (IN in)
                (NP
                  (NP (JJ perivascular) (NNS regions))
                  (PP (IN of)
                    (NP
                      (NP (NN RA))
                      (CONJP (CC but)
                        (RB not))
                      (NP (JJ normal) (JJ synovial) (NN tissue) (NN sublining)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB Moreover))
        (, ,)
        (NP (NNS pDCs))
        (VP (VBD were)
          (ADJP (JJ located)
            (PP (IN within)
              (NP (NN blood) (NNS vessels))))))
      (, ,)
      (CC and)
      (S
        (NP (DT both) (NN DC) (NNS populations))
        (VP (VBD were)
          (VP (VBN observed)
            (PP (IN in)
              (NP
                (NP (JJ perivascular) (NNS areas))
                (SBAR
                  (WHPP (IN in)
                    (WHNP (WDT which)))
                  (S
                    (NP
                      (NP (NNS cells))
                      (VP (VBG producing)
                        (NP (NN TNF-α))))
                    (VP (VBD were)
                      (VP (VBN colocated)
                        (NP (CD -LSB-35) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Adherence))
        (PP (IN of)
          (NP
            (NP (NN CD123+))
            (CC and)
            (NP (JJ CD11c+) (NNS DCs))))
        (PP (TO to)
          (NP (JJ TNF-α-activated) (NN endothelium))))
      (VP (VBD was)
        (ADJP
          (ADJP (JJR higher))
          (PP (IN than)
            (PP (TO to)
              (NP (VBG resting) (NN endothelium)))))
        (PP (IN in)
          (NP (FW vitro)))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (NN TNF-α))
      (VP
        (VP (VBZ plays)
          (NP (DT an) (JJ important) (NN role))
          (PP (IN in)
            (NP
              (NP (DT the) (NN recruitment))
              (PP (IN of)
                (NP (JJ other) (NNS leukocytes)))
              (PP (TO to)
                (NP
                  (ADJP (NN RA) (JJ synovial))
                  (NN tissue) (NN -LSB-29)))
              (-RRB- -RSB-))))
        (, ,)
        (CC and)
        (ADVP (DT this) (RBS most) (RB likely))
        (VP (VBZ pertains)
          (PP (TO to)
            (NP
              (NP (DT the) (NN recruitment))
              (PP (IN of)
                (NP (NN pDCs)))
              (PP (TO to)
                (NP
                  (NP (NN RA))
                  (CONJP (CC but)
                    (RB not))
                  (NP (JJ normal) (JJ synovial) (NN tissue))))))
          (PP (IN through)
            (NP
              (NP
                (NP (NN expression))
                (PP (IN of)
                  (NP
                    (NP (NN adhesion) (NNS molecules))
                    (PP (JJ such) (IN as)
                      (NP
                        (NP (JJ intercellular) (NN adhesion) (NN molecule) (-LRB- -LRB-) (NN ICAM) (-RRB- -RRB-) (CD -1))
                        (, ,)
                        (NP (NN CD62-E))
                        (, ,)
                        (CC and)
                        (NP (NN CD62-P)))))))
              (CC and)
              (NP
                (NP (NN interaction))
                (PP (IN with)
                  (NP
                    (NP (PRP$ their) (NNS ligands))
                    (PP (IN on)
                      (NP (NNS pDCs) (CD -LSB-9,11,51-54) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NN TNF-α))
      (VP (VBZ up-regulates)
        (NP
          (NP (NN synthesis))
          (PP (IN of)
            (NP (NNS chemokines))))
        (PP (IN by)
          (NP (JJ endothelial) (NNS cells)
            (NP (CD -LSB-55)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN During)
        (NP
          (ADJP (RB experimentally) (VBN elicited))
          (JJ allergic) (NN rhinitis)))
      (, ,)
      (NP (JJ CD123+HLA-DR+) (NNS pDCs))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN recruited)
                    (PP (TO to)
                      (NP (JJ human) (JJ nasal) (NN mucosa) (CD -LSB-11))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN gene))
        (PP (IN for)
          (NP (NN MxA))))
      (VP
        (VP (VBZ is)
          (ADVP (RB specifically))
          (VP (VBN induced)
            (PP (IN by)
              (NP (NN IFN-α)))))
        (CC and)
        (ADVP (RB therefore))
        (VP (VBZ identifies)
          (NP
            (NP (DT a) (NN population))
            (PP (IN of)
              (NP (VBN activated) (NNS pDCs)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (NN BDCA2))
      (VP (VBZ is)
        (NP
          (NP (DT a) (NN marker))
          (PP (IN of)
            (NP (JJ immature) (NNS pDCs))))))
    (. .)))

(
  (S
    (S
      (NP (JJ MxA+) (NNS pDCs))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN been)
          (VP (VBN demonstrated)
            (PP (IN in)
              (NP
                (NP (JJ involved) (NN lupus) (NN skin))
                (CC and)
                (NP (JJ inflamed) (NN tonsil) (NN -LSB-13))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN RA) (JJ synovial) (NN tissue)))
    (, ,)
    (NP (NN BDCA2))
    (VP (VBD was)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB stain)
              (NP (JJR fewer) (NNS cells))
              (PP (IN than)
                (NP
                  (NP (NN CD123))
                  (CC or)
                  (NP (NN MxA))))))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (NP
            (NP
              (NP (NN differentiation))
              (ADVP (FW in) (FW situ)))
            (PP (IN of)
              (NP
                (NP (DT a) (JJ large) (NN proportion))
                (PP (IN of)
                  (NP (NN pDCs)))))
            (PP (IN into)
              (NP
                (NP (NNS cells))
                (PP (IN with)
                  (NP
                    (NP (DT a) (NN capacity))
                    (PP (IN for)
                      (NP
                        (NP (NN production))
                        (PP (IN of)
                          (NP
                            (NP (NN IFN-α))
                            (CC and)
                            (NP (JJ other) (NNS cytokines))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Together))
      (, ,)
      (NP (DT the) (JJ current)
        (CC and)
        (JJ previous) (NNS studies))
      (VP (VBP demonstrate)
        (NP
          (NP
            (NP (NN recruitment))
            (PP (IN of)
              (NP (NNS pDCs)))
            (PP (TO to)
              (NP (JJ normal) (JJ lymphoid) (NNS organs))))
          (CONJP (RB as) (RB well) (IN as))
          (NP (JJ inflammatory) (NNS sites)))
        (, ,)
        (PP (IN with)
          (NP
            (NP (JJ local) (NN differentiation))
            (, ,)
            (CONJP (CC but)
              (RB no))
            (NP
              (NP (NN recruitment))
              (PP (TO to)
                (NP (JJ normal) (JJ peripheral) (NNS tissues))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (S
        (NP (JJ CD11c+) (JJ myeloid) (NNS precursors))
        (VP (VBP populate)
          (NP (JJ normal) (VBG resting) (NNS tissues))
          (, ,)
          (SBAR (IN as)
            (S
              (VP (VBN shown)
                (ADVP (RB here)))))))
      (, ,)
      (CC but)
      (S
        (NP (JJ additional) (JJ CD11c+) (JJ myeloid) (JJ cellular) (NN recruitment))
        (VP (VBZ takes)
          (NP (NN place))
          (PP (IN at)
            (NP
              (NP (JJ inflammatory) (NNS sites))
              (, ,)
              (SBAR
                (WHADVP (WRB where))
                (S
                  (NP (NN RelB) (JJ nuclear) (NN translocation))
                  (VP (VBZ takes)
                    (NP (NN place) (CD -LSB-21,56) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN shown)
          (SBAR (IN that)
            (S (, ,)
              (PP (IN like)
                (NP (JJ synovial) (NNS pDCs)))
              (, ,)
              (NP
                (NP (JJ CD123+) (NNS DCs))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN T-cell) (NN area))
                    (PP (IN of)
                      (NP (JJ human) (NN tonsil))))))
              (VP (VBP are)
                (ADVP (RB also))
                (NP (JJ nuclear) (NN RelB-) (NN -LSB-23)))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS data))
      (VP (VBP suggest)
        (SBAR (CC either)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN activation))
                (PP (IN of)
                  (NP (NNS pDCs))))
              (VP (VBZ is) (RB not)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (JJ nuclear) (NN translocation))
                        (CC and)
                        (NP (JJ transcriptional) (NN activity)))
                      (PP (IN of)
                        (NP (NN RelB)))))))))
          (CC or)
          (SBAR (IN that)
            (S
              (NP
                (NP (NNS conditions))
                (PP (IN in)
                  (NP
                    (NP (NN tonsil))
                    (CC and)
                    (NP (NN synovium)))))
              (VP (VBP do) (RB not)
                (VP (VB induce)
                  (NP (JJ sufficient) (NN RelB) (NN translocation))
                  (PP (IN for)
                    (NP
                      (NP (NN detection))
                      (PP (IN by)
                        (NP (NN immunohistochemistry) (CD -LSB-26,57)))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (SBAR (IN As)
      (S
        (NP
          (NP (JJ preliminary) (NNS studies))
          (ADJP (FW in) (FW vitro)))
        (VP (VBP demonstrate)
          (NP
            (NP
              (NP (NN induction))
              (PP (IN of)
                (NP (NN RelB)))
              (PP (IN in)
                (NP
                  (NP (NN PB) (NNS pDCs))
                  (PP (IN after)
                    (NP
                      (NP (NN stimulation))
                      (PP (IN with)
                        (NP
                          (NP (NN lipopolysaccharide))
                          (CC and)
                          (NP (NN CpG)))))))))
            (, ,)
            (CC and)
            (NP
              (NP (VBN reduced) (NN production))
              (PP (IN of)
                (NP (NN IFN-α)))
              (PP (IN by)
                (NP
                  (NP (NNS pDCs))
                  (PP (IN in)
                    (NP (JJ RelB-deficient) (NNS mice))))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP (JJ likely)
        (SBAR (IN that)
          (S
            (NP (NN RelB) (NN activation))
            (VP (VBZ does)
              (VP (VBP accompany)
                (NP (JJ pDC) (NN activation))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN RelB) (NN translocation))
      (VP (MD might)
        (VP (VB be)
          (ADVP (RB quantitatively))
          (VP (VBN reduced)))))
    (CC or)
    (S
      (NP (NN RelB))
      (VP (MD might)
        (VP (VB be)
          (VP
            (ADVP (RBR more) (RB rapidly))
            (VBN degraded)
            (PP (IN in)
              (NP
                (NP (DT the) (NN nucleus))
                (PP (IN of)
                  (NP (NNS pDCs)))))
            (PP (IN than)
              (FRAG
                (PP (IN of)
                  (NP
                    (NP (JJ myeloid) (NNS DCs))
                    (PP (IN in)
                      (NP (JJ inflamed) (NNS tissues)
                        (NP (CD -LSB-58))))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN Of) (NN relevance) (TO to)
        (NP (DT the) (NN RA) (JJ inflammatory) (NN lesion)))
      (, ,)
      (NP
        (NP (NN stimulation))
        (PP (IN of)
          (NP (NN blood) (JJ pDC) (NNS precursors)))
        (PP (IN with)
          (NP
            (NP (NNS signals))
            (PP (VBG including)
              (NP
                (NP (NN CD154))
                (, ,)
                (NP (NN influenza) (NN virus))
                (, ,)
                (CC or)
                (NP (NN CpG) (NNS oligonucleotides)))))))
      (VP (VBZ induces)
        (NP
          (NP (NN production))
          (PP (IN of)
            (NP
              (NP (JJ large) (NNS amounts))
              (PP (IN of)
                (NP
                  (NP (NNS cytokines))
                  (, ,)
                  (PP (VBG including)
                    (NP
                      (NP
                        (NP (NN IFN-α))
                        (, ,)
                        (NP (NN IFN-β))
                        (, ,)
                        (CC and)
                        (NP (NN TNF-α)))
                      (: ;)
                      (NP
                        (NP (NN induction))
                        (PP (IN of)
                          (NP (NN DC) (NN differentiation))))
                      (: ;)
                      (CC and)
                      (NP
                        (NP (NN stimulation))
                        (PP (IN of)
                          (NP (NN APC) (NN function) (CD -LSB-3,39,44,59))))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (JJ inhibitory) (NNS effects))
          (PP (IN of)
            (NP (NN SF)))
          (PP
            (PP (IN on)
              (NP (NN DC) (NN function)))
            (, ,)
            (CC and)
            (ADVP (RB thus))
            (PP (IN on)
              (NP
                (NP (NN T-cell) (NN proliferation))
                (CC and)
                (NP (NN cytokine) (NN production)))))
          (, ,))
        (VP (VBP are)
          (VP (VBN confirmed)
            (NP (RB here) (CD -LSB-21,39,60) (-RRB- -RSB-))))))
    (, ,)
    (NP
      (NP (NNS factors))
      (PP (IN in)
        (NP (DT the) (NN RA) (NN SF) (NN environment)))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP (NN IL-3))
          (CC and)
          (NP (NN CD154))))
      (, ,))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ sufficient)
          (S
            (VP (TO to)
              (VP (NN precondition)
                (NP (DT the) (NN SF) (NNS pDCs))
                (PP (IN for)
                  (NP (JJ efficient) (NN APC) (NN function)
                    (NP
                      (ADJP (FW ex) (FW vivo))
                      (NN -LSB-36,44) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN IFN-γ))
        (, ,)
        (NP (NN IL-10))
        (, ,)
        (CC and)
        (NP (NN TNF-α)))
      (VP (VBD were)
        (VP (VBN produced)
          (PP (IN in)
            (NP
              (NP (JJ mixed) (NN lymphocyte) (NNS reactions))
              (VP (VBN stimulated)
                (PP
                  (PP (IN by)
                    (NP
                      (NP (JJ myeloid) (NN or) (NNS pDCs))
                      (VP (VBN derived)
                        (PP (IN from)
                          (NP
                            (NP (NN SF))
                            (CONJP (CC but)
                              (RB not))
                            (NP (NN PB)))))))
                  (, ,)
                  (PP (RB potentially) (IN by)
                    (NP (NNS DCs)))
                  (CC or)
                  (PP (IN by)
                    (NP
                      (NP (NN T) (NNS cells))
                      (CC or)
                      (NP (DT both)))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT the) (NN tissue)))
    (, ,)
    (PP (IN as)
      (NP
        (NP (DT a) (NN result))
        (PP (IN of)
          (NP
            (NP (NN antigen) (NN presentation))
            (PP (IN by)
              (NP
                (NP (JJ myeloid) (NNS DCs))
                (CC or)
                (NP (NNS pDCs))))))))
    (, ,)
    (NP (JJ key) (NN effector) (NNS cytokines))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN produced)
          (PP (IN in)
            (NP
              (NP
                (NP
                  (NP (JJ perivascular) (NNS areas))
                  (PP (IN in)
                    (NP (NN RA))))
                (, ,)
                (NP
                  (NP (JJ located))
                  (ADJP (RB strategically) (JJ close)
                    (PP (TO to)
                      (NP (JJ endothelial) (NNS cells)))))
                (, ,))
              (CONJP (RB as) (RB well) (IN as))
              (NP (JJ incoming) (NNS leukocytes)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is) (RB not)
        (VP (VBN known)
          (SBAR (IN whether)
            (S
              (NP (NNS pDCs))
              (VP (VBP are)
                (ADJP (JJ capable))
                (, ,)
                (PP (IN like)
                  (NP (JJ myeloid) (NNS DCs)))
                (, ,)
                (PP (IN of)
                  (NP
                    (NP (NN migration))
                    (PP (IN from)
                      (NP (JJ synovial) (NN tissue)))
                    (PP (TO to)
                      (NP (JJ draining) (NN lymph) (NNS nodes)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (PRP it))
      (VP (VBZ seems)
        (ADJP (JJ probable))
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (NNS pDCs))
                (VP (VBN conditioned)
                  (PP (IN by)
                    (NP
                      (NP (JJ local) (NN IL-3))
                      (CC and)
                      (NP (NN CD154))))))
              (, ,)
              (CONJP (CC or)
                (RB even))
              (NP
                (NP
                  (ADJP
                    (ADJP (JJ viral))
                    (CC or)
                    (ADJP (JJ bacterial)))
                  (NNS products))
                (VP (VBN transported)
                  (PP (TO to)
                    (NP (DT the) (NN synovium)))))
              (, ,))
            (ADVP (RB predominantly))
            (VP (VBP play)
              (NP (JJ local)
                (ADJP
                  (ADJP (JJ proinflammatory))
                  (CC and)
                  (ADJP (JJ antigen-presenting)))
                (NNS roles))
              (, ,)
              (PP (IN through)
                (NP
                  (NP (NN secretion))
                  (PP (IN of)
                    (NP
                      (NP (NNS cytokines))
                      (PP (JJ such) (IN as)
                        (NP
                          (ADJP
                            (ADJP (JJ IFN-α))
                            (CC and)
                            (ADJP
                              (ADVP (RB possibly))
                              (JJ TNF-α)))
                          (NN -LSB-61,62) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (NP (NN Conclusion))))

(
  (S
    (S
      (NP (NNS pDCs))
      (VP
        (VP (VBP are)
          (VP (VBN recruited)
            (PP (TO to)
              (NP (NN RA) (JJ synovial) (NN tissue)))))
        (CC and)
        (VP (VBP comprise)
          (NP
            (NP (DT an) (NN APC) (NN population))
            (ADJP (JJ distinct)
              (PP (IN from)
                (NP (DT the)
                  (ADJP (RB previously) (VBN described))
                  (JJ nuclear) (NN RelB+) (JJ synovial) (NNS DCs))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN APC) (NN function))
        (PP (IN of)
          (NP (NNS pDCs))))
      (VP (VBZ is)
        (ADJP
          (ADJP (JJR greater))
          (PP (IN in)
            (NP (NN SF)))
          (PP (IN than)
            (PP (IN in)
              (NP (NN PB)))))))
    (. .)))

(
  (S
    (S
      (NP (VBN Activated)
        (NP
          (NP (NN pDCs))
          (CC and)
          (NP (NN interacting)))
        (NN T) (NNS cells))
      (VP (MD may)
        (VP (VB contribute)
          (ADVP (RB significantly))
          (PP (TO to)
            (NP
              (NP (DT the) (JJ inflammatory) (NN environment))
              (PP (IN in)
                (NP (NN RA))))))))
    (. .)))

(
  (S
    (NP (NNS Abbreviations))))

(
  (S
    (NP
      (NP
        (NP (NN APC) (JJ =) (JJ antigen-presenting) (NN cell))
        (: ;)
        (NP (NN DC) (JJ =) (JJ dendritic) (NN cell))
        (: ;)
        (NP (NN ELISA) (JJ =)
          (NP
            (NP (JJ enzyme-linked) (JJ immunosorbent) (NN assay))
            (: ;)
            (NP (NN FCS) (JJ =) (JJ fetal) (NN calf) (NN serum))
            (: ;)
            (NP (NN FITC) (JJ =) (NN fluorescein) (NN isothiocyanate))
            (: ;)
            (NP (NN IFN) (JJ =) (NN interferon) (: ;) (NN IL) (JJ =) (NN interleukin))
            (: ;))
          (NN NK) (JJ =) (JJ natural) (NN killer))
        (: ;)
        (NP (NN PB) (JJ =) (JJ peripheral) (NN blood))
        (: ;)
        (NP (JJ pDC) (JJ =) (NN plasmacytoid) (NN DC))
        (: ;)
        (NP (NN PE) (JJ =) (NN phycoerythrin))
        (: ;)
        (NP (NN RA) (JJ =) (JJ rheumatoid) (NN arthritis))
        (: ;)
        (NP (NN SF) (JJ =) (JJ synovial) (NN fluid)))
      (: ;)
      (NP (NN TNF) (JJ =) (NN tumor) (NN necrosis) (NN factor))
      (. .))))

(
  (S
    (NP (VBG Competing) (NNS interests))))

(
  (S
    (S
      (NP (DT The) (NN author) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-))
      (VP (VB declare)
        (SBAR (IN that)
          (S
            (NP (PRP they))
            (VP (VBP have)
              (NP (DT no) (VBG competing) (NNS interests)))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Authors) (POS '))
      (NNS contributions))))

(
  (S
    (S
      (S
        (NP
          (NP (NN LC))
          (, ,)
          (NP (NN RT))
          (, ,)
          (NP (NN LF))
          (, ,)
          (CC and)
          (NP (NN PP)))
        (VP (VBD conceived)
          (NP (DT the) (NNS experiments))))
      (CC and)
      (S
        (NP
          (NP (NN LC))
          (, ,)
          (NP (NN AB))
          (, ,)
          (NP (NN LS) (, ,) (NNP JP))
          (, ,)
          (CC and)
          (NP (NN LF)))
        (VP (VBD carried)
          (NP (PRP them))
          (ADVP (RP out)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN LC))
        (, ,)
        (NP (NN RT))
        (, ,)
        (CC and)
        (NP (NN LF)))
      (VP (VBP wrote)
        (NP (DT the) (NN manuscript))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1))
      (: :)
      (S
        (NP
          (NP (JJ Nuclear) (JJ RelB-CD123+) (NN plasmacytoid) (JJ dendritic) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP (NNS pDCs))
            (-RRB- -RRB-)))
        (VP (VBP are)
          (ADJP (JJ located)
            (PP (IN in)
              (NP
                (NP (JJ close) (NN association))
                (PP (IN with)
                  (NP
                    (NP (NNS cells))
                    (VP (VBG expressing)
                      (NP
                        (NP
                          (NP
                            (NP (NN tumor) (NN necrosis) (NN factor))
                            (PRN (-LRB- -LRB-)
                              (NP (NN TNF))
                              (-RRB- -RRB-)))
                          (NN -α))
                        (PP (IN in)
                          (NP
                            (NP (JJ lymphoid) (NNS aggregates))
                            (PP (IN of)
                              (NP
                                (NP
                                  (NP (JJ rheumatoid) (NN arthritis))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NN RA))
                                    (-RRB- -RRB-)))
                                (JJ synovial) (NN tissue))))))))))))))
      (. .))))

(
  (S
    (NP
      (NP
        (NP (NNS Sections))
        (PP (IN of)
          (NP
            (NP
              (NP (NN frozen) (JJ normal) (JJ human) (JJ synovial) (NN tissue))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN a))
                  (, ,)
                  (NP (NN b))
                  (, ,)
                  (NP (NN e)))
                (-RRB- -RRB-)))
            (CC or)
            (NP
              (NP
                (NP (JJ synovial) (NN tissue))
                (PP (IN from)
                  (NP
                    (NP (DT a) (NN patient))
                    (PP (IN with)
                      (NP (JJ untreated) (JJ active) (NN RA))))))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN c))
                  (, ,)
                  (NP (NN f))
                  (, ,)
                  (NP (NN g)))
                (-RRB- -RRB-))))))
      (CC or)
      (NP
        (NP (JJ formalin-fixed) (NNS sections))
        (PP (IN from)
          (NP
            (NP (DT a) (NN patient))
            (PP (IN with)
              (NP
                (NP (JJ active) (NN RA))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN d))
                    (, ,)
                    (NP (NN h)))
                  (, ,)
                  (NP (NN i))
                  (-RRB- -RRB-))))))))
    (VP (VBD were)
      (VP (VBN stained)
        (PP (IN with)
          (NP
            (NP
              (NP (NN anti-CD11c))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN brown))
                  (, ,)
                  (NP (NN a))
                  (, ,)
                  (NP (NN c)))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN anti-CD123))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN brown))
                  (, ,)
                  (NP (NN b))
                  (, ,)
                  (NP (NN d)))
                (-RRB- -RRB-)))
            (, ,)
            (CC or)
            (NP
              (NP (NN anti-TNF-α))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN brown))
                  (, ,)
                  (NP (NN g)))
                (-RRB- -RRB-)))))
        (S
          (VP (VBG using)
            (NP (DT an) (NN immunoperoxidase) (NN technique))))))
    (. .)))

(
  (S
    (PP (IN For)
      (NP (JJ double) (NN staining)))
    (, ,)
    (NP (NNS sections))
    (VP (VBD were)
      (VP (VBN stained)
        (PP
          (PP (IN with)
            (NP
              (NP
                (NP (NN Ulex))
                (PRN (-LRB- -LRB-)
                  (NP (JJ red))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (NN anti-CD123))
                (PRN (-LRB- -LRB-)
                  (NP (NN brown))
                  (, ,)
                  (NP
                    (NP (NN e))
                    (, ,)
                    (NP (NN f))
                    (, ,)
                    (NP (NN g)))
                  (-RRB- -RRB-)))))
          (CC or)
          (PP (IN with)
            (NP
              (NP
                (NP (NN RelB))
                (PRN (-LRB- -LRB-)
                  (NP (NN purple))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (NN CD123))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN brown))
                    (, ,)
                    (NP (NN h))
                    (, ,)
                    (NP (NN i)))
                  (-RRB- -RRB-))))))
        (S
          (VP (VBG using)
            (NP (DT a) (JJ double) (, ,) (JJ immunoperoxidase–immunoalkaline) (NN phosphatase) (NN technique))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS sections))
      (VP (VBD were)
        (ADJP (JJ counterstained)
          (PP (IN with)
            (NP
              (NP (NN hematoxylin))
              (PRN (-LRB- -LRB-)
                (NP (JJ blue))
                (-RRB- -RRB-)))))
        (PP (IN except)
          (NP
            (NP (NN h))
            (CC and)
            (NP (CD i))))
        (, ,)
        (SBAR
          (WHPP (IN in)
            (WHNP (WDT which)))
          (S
            (NP
              (NP (DT the) (NN nucleus))
              (PP (IN of)
                (NP (JJ CD123+) (NNS cells))))
            (VP (VBZ appears)
              (PP (IN as)
                (NP (DT a) (NN hole))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ thick) (NN arrow))
        (PP (IN in)
          (NP (NN d))))
      (VP (VBZ identifies)
        (NP (DT a) (NN blood) (NN vessel))))
    (. .)))

(
  (S
    (S
      (NP (NN Thin) (NNS arrows))
      (VP (VB denote)
        (NP
          (NP
            (NP (JJ representative) (JJ CD123+) (JJ perivascular) (NNS DCs))
            (PRN (-LRB- -LRB-)
              (NP (NN d))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ representative) (JJ double-stained) (NNS vessels))
            (PRN (-LRB- -LRB-)
              (NP (NN e))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (DT a) (JJ CD123+) (NN cell))
            (PP (IN within)
              (NP
                (NP (DT a) (NN blood) (NN vessel))
                (PRN (-LRB- -LRB-)
                  (NP (NN f))
                  (-RRB- -RRB-)))))
          (, ,)
          (CC and)
          (NP
            (NP (NNS nuclei))
            (VP (VBN stained)
              (PP (IN by)
                (NP (NN RelB) (-LRB- -LRB-) (NN h) (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBP are)
        (NP
          (NP (JJ representative))
          (PP (IN of)
            (NP
              (QP (IN at) (JJS least) (CD three))
              (JJ separate) (NN RA) (NNS donors)))
          (PP (IN in)
            (NP (JJ individual) (NNS experiments))))))
    (. .)))

(
  (S
    (S
      (NP (NN Scale) (NNS bars))
      (VP (VBP represent)
        (NP (CD 20) (NN μm))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 2))
      (: :)
      (S
        (NP
          (NP
            (NP (JJ CD123+) (JJ dendritic) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NNS DCs))
              (-RRB- -RRB-)))
          (CC and)
          (NP (JJ CD11c+) (NNS cells)))
        (VP (VBP are)
          (VP (VBN enriched)
            (PP (IN in)
              (NP
                (NP
                  (NP
                    (NP (JJ rheumatoid) (NN arthritis))
                    (PRN (-LRB- -LRB-)
                      (NP (NN RA))
                      (-RRB- -RRB-)))
                  (JJ synovial) (NN tissue))
                (PRN (-LRB- -LRB-)
                  (NP (JJ ST))
                  (-RRB- -RRB-)))))))
      (. .))))

(
  (S
    (S
      (NP (NN CD123+) (NNS DCs))
      (VP (VBD were)
        (VP (VBN quantitated)
          (PP (IN by)
            (S
              (VP (VBG counting)
                (NP
                  (NP (DT the) (NN number))
                  (PP (IN of)
                    (NP (NN CD123+Ulex-) (NNS cells))))
                (PP (IN in)
                  (NP
                    (NP (NNS sections))
                    (VP (VBN double-stained)
                      (PP (IN with)
                        (NP
                          (NP (NN CD123))
                          (CC and)
                          (NP (NN Ulex)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Cells))
        (VP (VBD were)
          (VP (VBN counted)
            (PP (IN in)
              (NP
                (NP (DT each))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ entire) (NNS sections))
                    (PP (IN from)
                      (NP
                        (NP
                          (NP (CD three) (NNS patients))
                          (CC and)
                          (NP (CD three) (JJ normal) (NNS controls)))
                        (PP (IN at)
                          (NP (JJ high) (NN power))))))))))))
      (, ,)
      (CC and)
      (S
        (PP (IN for)
          (NP (DT each) (NN biopsy)))
        (NP (DT this) (NN number))
        (VP (VBD was)
          (VP (VBN corrected)
            (PP (IN for)
              (NP
                (NP (DT the) (NN area))
                (PP (IN of)
                  (NP (DT the) (NN section)
                    (S
                      (VP (TO to)
                        (VP (VB obtain)
                          (NP (DT the) (NNS number/mm2)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB quantitate)
            (NP (JJ CD11c+) (JJ cellular) (NN infiltration)))))
      (, ,)
      (NP
        (NP (DT the) (NN number))
        (PP (IN of)
          (NP (NN CD11c+) (NNS cells))))
      (VP (VBD was)
        (VP (VBN counted)
          (PP (IN in)
            (NP
              (NP (CD three) (JJ high-power) (NNS fields))
              (PP (IN of)
                (NP
                  (NP (DT the) (JJ synovial) (NN sublining))
                  (PP (IN in)
                    (NP
                      (NP (NNS sections))
                      (PP (IN from)
                        (NP
                          (NP (CD three) (NNS patients))
                          (CC and)
                          (NP (CD three) (JJ normal) (NNS controls)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBP represent)
        (NP
          (NP (NN means) (NN ±) (JJ standard) (NN error))
          (PP (IN of)
            (NP (DT the) (NN mean))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (S
        (NP
          (NP
            (NP (JJ CD11c+) (JJ dendritic) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NNS DCs))
              (-RRB- -RRB-)))
          (CC and)
          (NP (JJ CD123+) (NNS DCs)))
        (VP (VBP are)
          (ADJP (JJ present)
            (PP (IN in)
              (NP
                (NP
                  (NP
                    (NP (JJ rheumatoid) (NN arthritis))
                    (PRN (-LRB- -LRB-)
                      (NP (NN RA))
                      (-RRB- -RRB-)))
                  (JJ synovial) (NN fluid))
                (PRN (-LRB- -LRB-)
                  (NP (NN SF))
                  (-RRB- -RRB-)))))))
      (. .))))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN purification))
          (PP (IN of)
            (NP
              (NP (JJ mononuclear) (NNS cells))
              (PP (IN from)
                (NP (CC either)
                  (NP
                    (NP (JJ normal)
                      (CC or)
                      (NN RA) (JJ peripheral) (NN blood))
                    (PRN (-LRB- -LRB-)
                      (NP (NN PB))
                      (-RRB- -RRB-)))
                  (CC or)
                  (NP (NN RA) (NN SF))))))))
      (, ,)
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NN CD123-PE))
              (, ,)
              (NP (NN CD11c) (NN FITC))
              (, ,)
              (NP (NN CD14-PECy5))
              (, ,)
              (CC and)
              (NP (NN HLA-DR-APC)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Live) (JJ HLA-DR+CD14-) (JJ mononuclear) (NNS cells))
      (VP (VBD were)
        (VP (VBN gated))))
    (: ;)
    (S
      (NP (JJ polymorphonuclear) (NNS cells))
      (VP (VBD were)
        (VP (VBN excluded)
          (PP (IN on)
            (NP
              (NP (DT the) (NN basis))
              (PP (IN of)
                (NP
                  (ADJP
                    (ADJP (JJ forward))
                    (CC and)
                    (ADJP (JJ side)))
                  (NN light-scatter))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Scatter) (NNS plots))
      (VP (VB depict)
        (NP
          (NP (NN percentage))
          (PP (IN of)
            (NP
              (NP (JJ total) (NN PB))
              (CC or)
              (NP
                (NP (NN SF) (NNS cells))
                (VP (VBG expressing)
                  (NP
                    (NP (DT the) (VBN indicated) (NNS markers))
                    (PP (IN for)
                      (NP (DT all) (NNS donors)))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN APC))
      (, ,)
      (NP
        (NP (JJ antigen-presenting) (NN cell))
        (: ;)
        (NP
          (NP (NN PBMC))
          (, ,)
          (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))
          (: ;)
          (NP (NN PE))
          (, ,)
          (NP (NN phycoerythrin))
          (: ;)
          (NP (NN SFMC))
          (, ,)
          (NP (JJ synovial) (NN fluid) (JJ mononuclear) (NNS cells))))
      (. .))))

(
  (S
    (NP
      (NP (NN Figure) (CD 4))
      (: :)
      (NP
        (NP
          (NP (NN Morphology))
          (CC and)
          (NP (NN cell-surface) (NN phenotype)))
        (PP (IN of)
          (NP
            (NP
              (NP (JJ dendritic) (NN cell))
              (PRN (-LRB- -LRB-)
                (NP (NN DC))
                (-RRB- -RRB-)))
            (NNS subpopulations))))
      (. .))))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-))
      (NP
        (NP
          (ADJP (RB Freshly) (VBN isolated))
          (NN CD11c+CD123-) (NNS DCs))
        (CC and)
        (NP (JJ CD123+CD11c-) (NNS DCs)))
      (VP
        (VP (VBD were)
          (VP (VBN sorted)
            (PP (IN from)
              (NP (CC either)
                (NP
                  (NP (JJ normal) (JJ peripheral) (NN blood))
                  (PRN (-LRB- -LRB-)
                    (NP (NN PB))
                    (-RRB- -RRB-)))
                (CC or)
                (NP
                  (NP (JJ rheumatoid) (NN arthritis))
                  (PRN (-LRB- -LRB-)
                    (NP (NN RA))
                    (-RRB- -RRB-)))
                (NP
                  (NP (JJ synovial) (NN fluid))
                  (PRN (-LRB- -LRB-)
                    (NP (NN SF))
                    (-RRB- -RRB-)))))
            (PP (VBG according)
              (PP (TO to)
                (NP
                  (NP (DT the) (JJ gating) (NN strategy))
                  (VP (VBN outlined)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN legend))
                        (PP (TO to)
                          (NP (NNP Fig.) (CD 3)))))))))))
        (CC and)
        (VP (VBD were)
          (ADVP (RB then))
          (VP (VBN prepared)
            (PP (IN for)
              (NP (NN transmission) (NN electron) (NN microscopy)))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Micrographs))
      (VP (VBP are)
        (NP
          (NP (JJ representative))
          (PP (IN of)
            (NP (CD three) (JJ separate) (NNS donors))))))
    (. .)))

(
  (S
    (S
      (NP (NN Scale) (NNS bars))
      (VP (VBP represent)
        (NP (CD 20) (NN μm))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-))
          (JJ Normal) (NN PB))
        (CC or)
        (NP (NN RA) (NN SF) (JJ mononuclear) (NNS cells)))
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (NN CD123-PE))
              (, ,)
              (NP (NN CD14-PECy5))
              (, ,)
              (NP (NN HLA-DR-APC))
              (, ,)
              (CC and)
              (NP (CC either)
                (NP (NN isotype) (NN control))
                (CC or)
                (NP
                  (NP (DT the) (VBN depicted) (NN marker))
                  (VP (VBN labelled)
                    (PP (IN with)
                      (NP (NN FITC)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Live) (JJ HLA-DR+CD14-CD123+) (NNS cells))
        (CC or)
        (NP (JJ HLA-DR+CD14-CD11c+) (NNS cells)))
      (VP (VBD were)
        (VP (VBN gated))))
    (: ;)
    (S
      (NP (JJ polymorphonuclear) (NNS cells))
      (VP (VBD were)
        (VP (VBN excluded)
          (PP (IN on)
            (NP
              (NP (DT the) (NN basis))
              (PP (IN of)
                (NP
                  (ADJP
                    (ADJP (JJ forward))
                    (CC and)
                    (ADJP (JJ side)))
                  (NN light-scatter))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN expression))
        (PP (IN of)
          (NP
            (NP
              (NP (NN isotype) (NN control))
              (PRN (-LRB- -LRB-)
                (NP (JJ dotted) (NNS lines))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (VBN indicated) (NNS markers))
              (PRN (-LRB- -LRB-)
                (NP (JJ continuous) (NNS lines))
                (-RRB- -RRB-)))))
        (PP (IN by)
          (NP (DT the) (JJ gated) (NNS cells))))
      (VP (VBP are)
        (VP (VBN depicted))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBP are)
        (PP (IN from)
          (NP
            (NP (CD three) (NNS donors))
            (PP (IN of)
              (NP
                (NP (JJ normal) (NN PB))
                (CC or)
                (NP (NN RA) (NN SF))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN APC))
        (, ,)
        (NP (JJ antigen-presenting) (NN cell) (: ;) (NN PE))
        (, ,))
      (NP (NN phycoerythrin)))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (S
        (NP
          (S
            (NP
              (NP (NN CD123+))
              (CC and)
              (NP
                (NP (JJ CD11c+) (JJ synovial) (NN fluid))
                (PRN (-LRB- -LRB-)
                  (NP (NN SF))
                  (-RRB- -RRB-)))
              (NP
                (NP (JJ dendritic) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NNS DCs))
                  (-RRB- -RRB-))))
            (VP
              (VP (VBP are)
                (NP
                  (NP (JJ efficient) (JJ antigen-presenting) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NNS APCs))
                    (-RRB- -RRB-))))
              (CC and)
              (VP (VB induce)
                (NP (NN secretion))
                (PP (IN of)
                  (NP (NN tumor) (NN necrosis) (NN factor) (NN α.))))))
          (NP
            (ADJP (RB Freshly) (VBN sorted))
            (NN CD123+CD11c-))
          (CC or)
          (NP
            (NP (JJ CD11c+CD123-) (NNS DCs))
            (PP (IN from)
              (NP (CC either)
                (NP
                  (NP
                    (NP (JJ normal) (JJ peripheral) (NN blood))
                    (PRN (-LRB- -LRB-)
                      (NP (NN PB))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP (NN a–d))
                    (-RRB- -RRB-)))
                (CC or)
                (NP (JJ rheumatoid) (NN arthritis) (-LRB- -LRB-) (NN RA) (-RRB- -RRB-) (NN SF) (-LRB- -LRB-) (CD e–h) (-RRB- -RRB-))))))
        (VP (VBD were)
          (VP (VBN incubated)
            (PP (IN with)
              (NP (CD 105) (VBN purified) (JJ normal) (JJ allogeneic) (NN T) (NNS cells))))))
      (. .))))

(
  (S
    (S
      (NP (NN T-cell) (NN proliferation))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN by)
            (NP
              (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine) (NN incorporation))
              (PP (IN of)
                (NP (JJ triplicate) (NNS wells)))
              (PP (IN after)
                (NP
                  (NP (CD 60) (NNS hours))
                  (PRN (-LRB- -LRB-)
                    (NP (NN a))
                    (, ,)
                    (NP (NN e))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Unstimulated) (NN T-cell) (NN proliferation))
      (VP (VBD was)
        (ADVP (RB routinely))
        (NP (CD <500) (NN cpm))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP
        (VP (VBP represent)
          (NP
            (NP (NN means) (NN ±) (JJ standard) (NN error))
            (PP (IN of)
              (NP
                (NP (DT the) (NN mean))
                (PP (IN of)
                  (NP (JJ triplicate) (NNS wells)))))))
        (CC and)
        (VP (VBP are)
          (PP (IN from)
            (NP (CD three) (JJ individual)
              (NP
                (NP (NN PB))
                (CC and)
                (NP (NN SF)))
              (NNS donors))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS concentrations))
        (PP (IN of)
          (NP
            (NP (NN IFNγ))
            (, ,)
            (NP (NN IL-10))
            (, ,)
            (CC and)
            (NP (NN tumor) (NN necrosis) (NN factor)
              (PRN (-LRB- -LRB-)
                (NP (NN TNF))
                (-RRB- -RRB-))
              (CD -α)))))
      (VP (VBD were)
        (VP (VBN measured)
          (PP (IN in)
            (NP
              (NP (NNS supernatants))
              (PP (IN of)
                (NP
                  (NP (JJ allogeneic) (JJ mixed) (NN lymphocyte) (NNS reactions))
                  (VP (VBN stimulated)
                    (PP (IN by)
                      (NP
                        (NP
                          (NP (VBN sorted) (NN PB))
                          (PRN (-LRB- -LRB-)
                            (NP (NN b–d))
                            (-RRB- -RRB-)))
                        (CC or)
                        (NP
                          (NP (NN SF) (NNS DCs))
                          (PRN (-LRB- -LRB-)
                            (NP (NN f–h))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP
        (VP (VBP are)
          (NP
            (NP (NNS means))
            (PP (IN of)
              (NP (JJ duplicate) (NNS samples)))))
        (CC and)
        (VP (VBP are)
          (PP (IN from)
            (NP (CD two) (JJ separate) (NN SF) (NNS donors))))))
    (. .)))

